country,alpha_2_code,alpha_3_code,numeric_code,indicator,time_period,obs_value,sex,unit_multiplier,unit_of_measure,observation_status,observation_confidentaility,time_period_activity_related_to_when_the_data_are_collected,current_age
Afghanistan,AF,AFG,4,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2014,49,Total,Units,%,Estimated value,Free,,12 to 23 months old
Afghanistan,AF,AFG,4,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2015,65,Total,Units,%,Estimated value,Free,,12 to 23 months old
Afghanistan,AF,AFG,4,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2016,62,Total,Units,%,Estimated value,Free,,12 to 23 months old
Afghanistan,AF,AFG,4,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2017,66,Total,Units,%,Estimated value,Free,,12 to 23 months old
Afghanistan,AF,AFG,4,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2018,69,Total,Units,%,Estimated value,Free,,12 to 23 months old
Afghanistan,AF,AFG,4,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2019,68,Total,Units,%,Estimated value,Free,,12 to 23 months old
Afghanistan,AF,AFG,4,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2020,68,Total,Units,%,Estimated value,Free,,12 to 23 months old
Afghanistan,AF,AFG,4,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2021,65,Total,Units,%,Estimated value,Free,,12 to 23 months old
Afghanistan,AF,AFG,4,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2022,67,Total,Units,%,Estimated value,Free,,12 to 23 months old
Albania,AL,ALB,8,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2011,99,Total,Units,%,Estimated value,Free,,12 to 23 months old
Albania,AL,ALB,8,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2012,99,Total,Units,%,Estimated value,Free,,12 to 23 months old
Albania,AL,ALB,8,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2013,99,Total,Units,%,Estimated value,Free,,12 to 23 months old
Albania,AL,ALB,8,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2014,99,Total,Units,%,Estimated value,Free,,12 to 23 months old
Albania,AL,ALB,8,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2015,99,Total,Units,%,Estimated value,Free,,12 to 23 months old
Albania,AL,ALB,8,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2016,98,Total,Units,%,Estimated value,Free,,12 to 23 months old
Albania,AL,ALB,8,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2017,99,Total,Units,%,Estimated value,Free,,12 to 23 months old
Albania,AL,ALB,8,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2018,98,Total,Units,%,Estimated value,Free,,12 to 23 months old
Albania,AL,ALB,8,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2019,96,Total,Units,%,Estimated value,Free,,12 to 23 months old
Albania,AL,ALB,8,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2020,92,Total,Units,%,Estimated value,Free,,12 to 23 months old
Albania,AL,ALB,8,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2021,89,Total,Units,%,Estimated value,Free,,12 to 23 months old
Albania,AL,ALB,8,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2022,87,Total,Units,%,Estimated value,Free,,12 to 23 months old
Algeria,DZ,DZA,12,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2016,61,Total,Units,%,Estimated value,Free,,12 to 23 months old
Algeria,DZ,DZA,12,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2017,89,Total,Units,%,Estimated value,Free,,12 to 23 months old
Algeria,DZ,DZA,12,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2018,91,Total,Units,%,Estimated value,Free,,12 to 23 months old
Algeria,DZ,DZA,12,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2019,87,Total,Units,%,Estimated value,Free,,12 to 23 months old
Algeria,DZ,DZA,12,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2020,83,Total,Units,%,Estimated value,Free,,12 to 23 months old
Algeria,DZ,DZA,12,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2021,78,Total,Units,%,Estimated value,Free,,12 to 23 months old
Algeria,DZ,DZA,12,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2022,74,Total,Units,%,Estimated value,Free,,12 to 23 months old
Andorra,AD,AND,20,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2014,93,Total,Units,%,Estimated value,Free,,12 to 23 months old
Andorra,AD,AND,20,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2015,92,Total,Units,%,Estimated value,Free,,12 to 23 months old
Andorra,AD,AND,20,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2016,92,Total,Units,%,Estimated value,Free,,12 to 23 months old
Andorra,AD,AND,20,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2017,98,Total,Units,%,Estimated value,Free,,12 to 23 months old
Andorra,AD,AND,20,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2018,94,Total,Units,%,Estimated value,Free,,12 to 23 months old
Andorra,AD,AND,20,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2019,96,Total,Units,%,Estimated value,Free,,12 to 23 months old
Andorra,AD,AND,20,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2020,96,Total,Units,%,Estimated value,Free,,12 to 23 months old
Andorra,AD,AND,20,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2021,95,Total,Units,%,Estimated value,Free,,12 to 23 months old
Andorra,AD,AND,20,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2022,95,Total,Units,%,Estimated value,Free,,12 to 23 months old
Angola,AO,AGO,24,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2013,9,Total,Units,%,Estimated value,Free,,12 to 23 months old
Angola,AO,AGO,24,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2014,45,Total,Units,%,Estimated value,Free,,12 to 23 months old
Angola,AO,AGO,24,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2015,55,Total,Units,%,Estimated value,Free,,12 to 23 months old
Angola,AO,AGO,24,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2016,55,Total,Units,%,Estimated value,Free,,12 to 23 months old
Angola,AO,AGO,24,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2017,52,Total,Units,%,Estimated value,Free,,12 to 23 months old
Angola,AO,AGO,24,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2018,59,Total,Units,%,Estimated value,Free,,12 to 23 months old
Angola,AO,AGO,24,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2019,53,Total,Units,%,Estimated value,Free,,12 to 23 months old
Angola,AO,AGO,24,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2020,53,Total,Units,%,Estimated value,Free,,12 to 23 months old
Angola,AO,AGO,24,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2021,34,Total,Units,%,Estimated value,Free,,12 to 23 months old
Angola,AO,AGO,24,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2022,24,Total,Units,%,Estimated value,Free,,12 to 23 months old
Argentina,AR,ARG,32,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2012,41,Total,Units,%,Estimated value,Free,,12 to 23 months old
Argentina,AR,ARG,32,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2013,86,Total,Units,%,Estimated value,Free,,12 to 23 months old
Argentina,AR,ARG,32,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2014,89,Total,Units,%,Estimated value,Free,,12 to 23 months old
Argentina,AR,ARG,32,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2015,82,Total,Units,%,Estimated value,Free,,12 to 23 months old
Argentina,AR,ARG,32,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2016,82,Total,Units,%,Estimated value,Free,,12 to 23 months old
Argentina,AR,ARG,32,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2017,76,Total,Units,%,Estimated value,Free,,12 to 23 months old
Argentina,AR,ARG,32,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2018,88,Total,Units,%,Estimated value,Free,,12 to 23 months old
Argentina,AR,ARG,32,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2019,80,Total,Units,%,Estimated value,Free,,12 to 23 months old
Argentina,AR,ARG,32,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2020,75,Total,Units,%,Estimated value,Free,,12 to 23 months old
Argentina,AR,ARG,32,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2021,79,Total,Units,%,Estimated value,Free,,12 to 23 months old
Argentina,AR,ARG,32,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2022,77,Total,Units,%,Estimated value,Free,,12 to 23 months old
Armenia,AM,ARM,51,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2015,44,Total,Units,%,Estimated value,Free,,12 to 23 months old
Armenia,AM,ARM,51,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2016,94,Total,Units,%,Estimated value,Free,,12 to 23 months old
Armenia,AM,ARM,51,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2017,94,Total,Units,%,Estimated value,Free,,12 to 23 months old
Armenia,AM,ARM,51,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2018,92,Total,Units,%,Estimated value,Free,,12 to 23 months old
Armenia,AM,ARM,51,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2019,92,Total,Units,%,Estimated value,Free,,12 to 23 months old
Armenia,AM,ARM,51,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2020,92,Total,Units,%,Estimated value,Free,,12 to 23 months old
Armenia,AM,ARM,51,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2021,93,Total,Units,%,Estimated value,Free,,12 to 23 months old
Armenia,AM,ARM,51,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2022,93,Total,Units,%,Estimated value,Free,,12 to 23 months old
Australia,AU,AUS,36,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2008,91,Total,Units,%,Estimated value,Free,,12 to 23 months old
Australia,AU,AUS,36,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2009,91,Total,Units,%,Estimated value,Free,,12 to 23 months old
Australia,AU,AUS,36,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2010,91,Total,Units,%,Estimated value,Free,,12 to 23 months old
Australia,AU,AUS,36,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2011,91,Total,Units,%,Estimated value,Free,,12 to 23 months old
Australia,AU,AUS,36,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2012,91,Total,Units,%,Estimated value,Free,,12 to 23 months old
Australia,AU,AUS,36,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2013,91,Total,Units,%,Estimated value,Free,,12 to 23 months old
Australia,AU,AUS,36,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2014,91,Total,Units,%,Estimated value,Free,,12 to 23 months old
Australia,AU,AUS,36,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2015,93,Total,Units,%,Estimated value,Free,,12 to 23 months old
Australia,AU,AUS,36,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2016,94,Total,Units,%,Estimated value,Free,,12 to 23 months old
Australia,AU,AUS,36,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2017,94,Total,Units,%,Estimated value,Free,,12 to 23 months old
Australia,AU,AUS,36,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2018,95,Total,Units,%,Estimated value,Free,,12 to 23 months old
Australia,AU,AUS,36,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2019,96,Total,Units,%,Estimated value,Free,,12 to 23 months old
Australia,AU,AUS,36,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2020,97,Total,Units,%,Estimated value,Free,,12 to 23 months old
Australia,AU,AUS,36,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2021,96,Total,Units,%,Estimated value,Free,,12 to 23 months old
Australia,AU,AUS,36,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2022,96,Total,Units,%,Estimated value,Free,,12 to 23 months old
Azerbaijan,AZ,AZE,31,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2014,64,Total,Units,%,Estimated value,Free,,12 to 23 months old
Azerbaijan,AZ,AZE,31,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2015,94,Total,Units,%,Estimated value,Free,,12 to 23 months old
Azerbaijan,AZ,AZE,31,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2016,97,Total,Units,%,Estimated value,Free,,12 to 23 months old
Azerbaijan,AZ,AZE,31,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2017,96,Total,Units,%,Estimated value,Free,,12 to 23 months old
Azerbaijan,AZ,AZE,31,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2018,95,Total,Units,%,Estimated value,Free,,12 to 23 months old
Azerbaijan,AZ,AZE,31,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2019,95,Total,Units,%,Estimated value,Free,,12 to 23 months old
Azerbaijan,AZ,AZE,31,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2020,79,Total,Units,%,Estimated value,Free,,12 to 23 months old
Azerbaijan,AZ,AZE,31,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2021,90,Total,Units,%,Estimated value,Free,,12 to 23 months old
Azerbaijan,AZ,AZE,31,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2022,83,Total,Units,%,Estimated value,Free,,12 to 23 months old
Bahamas,BS,BHS,44,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2009,3,Total,Units,%,Estimated value,Free,,12 to 23 months old
Bahamas,BS,BHS,44,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2010,1,Total,Units,%,Estimated value,Free,,12 to 23 months old
Bahamas,BS,BHS,44,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2011,1,Total,Units,%,Estimated value,Free,,12 to 23 months old
Bahamas,BS,BHS,44,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2012,37,Total,Units,%,Estimated value,Free,,12 to 23 months old
Bahamas,BS,BHS,44,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2013,97,Total,Units,%,Estimated value,Free,,12 to 23 months old
Bahamas,BS,BHS,44,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2014,96,Total,Units,%,Estimated value,Free,,12 to 23 months old
Bahamas,BS,BHS,44,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2015,95,Total,Units,%,Estimated value,Free,,12 to 23 months old
Bahamas,BS,BHS,44,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2016,94,Total,Units,%,Estimated value,Free,,12 to 23 months old
Bahamas,BS,BHS,44,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2017,93,Total,Units,%,Estimated value,Free,,12 to 23 months old
Bahamas,BS,BHS,44,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2018,90,Total,Units,%,Estimated value,Free,,12 to 23 months old
Bahamas,BS,BHS,44,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2019,89,Total,Units,%,Estimated value,Free,,12 to 23 months old
Bahamas,BS,BHS,44,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2020,83,Total,Units,%,Estimated value,Free,,12 to 23 months old
Bahamas,BS,BHS,44,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2021,80,Total,Units,%,Estimated value,Free,,12 to 23 months old
Bahamas,BS,BHS,44,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2022,79,Total,Units,%,Estimated value,Free,,12 to 23 months old
Bahrain,BH,BHR,48,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2008,14,Total,Units,%,Estimated value,Free,,12 to 23 months old
Bahrain,BH,BHR,48,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2009,96,Total,Units,%,Estimated value,Free,,12 to 23 months old
Bahrain,BH,BHR,48,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2010,99,Total,Units,%,Estimated value,Free,,12 to 23 months old
Bahrain,BH,BHR,48,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2011,99,Total,Units,%,Estimated value,Free,,12 to 23 months old
Bahrain,BH,BHR,48,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2012,99,Total,Units,%,Estimated value,Free,,12 to 23 months old
Bahrain,BH,BHR,48,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2013,99,Total,Units,%,Estimated value,Free,,12 to 23 months old
Bahrain,BH,BHR,48,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2014,99,Total,Units,%,Estimated value,Free,,12 to 23 months old
Bahrain,BH,BHR,48,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2015,98,Total,Units,%,Estimated value,Free,,12 to 23 months old
Bahrain,BH,BHR,48,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2016,99,Total,Units,%,Estimated value,Free,,12 to 23 months old
Bahrain,BH,BHR,48,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2017,97,Total,Units,%,Estimated value,Free,,12 to 23 months old
Bahrain,BH,BHR,48,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2018,98,Total,Units,%,Estimated value,Free,,12 to 23 months old
Bahrain,BH,BHR,48,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2019,97,Total,Units,%,Estimated value,Free,,12 to 23 months old
Bahrain,BH,BHR,48,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2020,99,Total,Units,%,Estimated value,Free,,12 to 23 months old
Bahrain,BH,BHR,48,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2021,99,Total,Units,%,Estimated value,Free,,12 to 23 months old
Bahrain,BH,BHR,48,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2022,99,Total,Units,%,Estimated value,Free,,12 to 23 months old
Bangladesh,BD,BGD,50,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2015,48,Total,Units,%,Estimated value,Free,,12 to 23 months old
Bangladesh,BD,BGD,50,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2016,97,Total,Units,%,Estimated value,Free,,12 to 23 months old
Bangladesh,BD,BGD,50,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2017,99,Total,Units,%,Estimated value,Free,,12 to 23 months old
Bangladesh,BD,BGD,50,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2018,99,Total,Units,%,Estimated value,Free,,12 to 23 months old
Bangladesh,BD,BGD,50,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2019,99,Total,Units,%,Estimated value,Free,,12 to 23 months old
Bangladesh,BD,BGD,50,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2020,99,Total,Units,%,Estimated value,Free,,12 to 23 months old
Bangladesh,BD,BGD,50,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2021,99,Total,Units,%,Estimated value,Free,,12 to 23 months old
Bangladesh,BD,BGD,50,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2022,99,Total,Units,%,Estimated value,Free,,12 to 23 months old
Barbados,BB,BRB,52,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2009,75,Total,Units,%,Estimated value,Free,,12 to 23 months old
Barbados,BB,BRB,52,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2010,78,Total,Units,%,Estimated value,Free,,12 to 23 months old
Barbados,BB,BRB,52,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2011,81,Total,Units,%,Estimated value,Free,,12 to 23 months old
Barbados,BB,BRB,52,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2012,84,Total,Units,%,Estimated value,Free,,12 to 23 months old
Barbados,BB,BRB,52,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2013,87,Total,Units,%,Estimated value,Free,,12 to 23 months old
Barbados,BB,BRB,52,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2014,90,Total,Units,%,Estimated value,Free,,12 to 23 months old
Barbados,BB,BRB,52,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2015,97,Total,Units,%,Estimated value,Free,,12 to 23 months old
Barbados,BB,BRB,52,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2016,96,Total,Units,%,Estimated value,Free,,12 to 23 months old
Barbados,BB,BRB,52,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2017,89,Total,Units,%,Estimated value,Free,,12 to 23 months old
Barbados,BB,BRB,52,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2018,89,Total,Units,%,Estimated value,Free,,12 to 23 months old
Barbados,BB,BRB,52,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2019,93,Total,Units,%,Estimated value,Free,,12 to 23 months old
Barbados,BB,BRB,52,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2020,86,Total,Units,%,Estimated value,Free,,12 to 23 months old
Barbados,BB,BRB,52,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2021,83,Total,Units,%,Estimated value,Free,,12 to 23 months old
Barbados,BB,BRB,52,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2022,87,Total,Units,%,Estimated value,Free,,12 to 23 months old
Belgium,BE,BEL,56,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2012,93,Total,Units,%,Estimated value,Free,,12 to 23 months old
Belgium,BE,BEL,56,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2013,93,Total,Units,%,Estimated value,Free,,12 to 23 months old
Belgium,BE,BEL,56,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2014,93,Total,Units,%,Estimated value,Free,,12 to 23 months old
Belgium,BE,BEL,56,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2015,94,Total,Units,%,Estimated value,Free,,12 to 23 months old
Belgium,BE,BEL,56,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2016,94,Total,Units,%,Estimated value,Free,,12 to 23 months old
Belgium,BE,BEL,56,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2017,94,Total,Units,%,Estimated value,Free,,12 to 23 months old
Belgium,BE,BEL,56,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2018,94,Total,Units,%,Estimated value,Free,,12 to 23 months old
Belgium,BE,BEL,56,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2019,94,Total,Units,%,Estimated value,Free,,12 to 23 months old
Belgium,BE,BEL,56,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2020,94,Total,Units,%,Estimated value,Free,,12 to 23 months old
Belgium,BE,BEL,56,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2021,94,Total,Units,%,Estimated value,Free,,12 to 23 months old
Belgium,BE,BEL,56,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2022,94,Total,Units,%,Estimated value,Free,,12 to 23 months old
Benin,BJ,BEN,204,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2011,36,Total,Units,%,Estimated value,Free,,12 to 23 months old
Benin,BJ,BEN,204,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2012,67,Total,Units,%,Estimated value,Free,,12 to 23 months old
Benin,BJ,BEN,204,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2013,70,Total,Units,%,Estimated value,Free,,12 to 23 months old
Benin,BJ,BEN,204,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2014,69,Total,Units,%,Estimated value,Free,,12 to 23 months old
Benin,BJ,BEN,204,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2015,72,Total,Units,%,Estimated value,Free,,12 to 23 months old
Benin,BJ,BEN,204,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2016,73,Total,Units,%,Estimated value,Free,,12 to 23 months old
Benin,BJ,BEN,204,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2017,73,Total,Units,%,Estimated value,Free,,12 to 23 months old
Benin,BJ,BEN,204,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2018,73,Total,Units,%,Estimated value,Free,,12 to 23 months old
Benin,BJ,BEN,204,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2019,73,Total,Units,%,Estimated value,Free,,12 to 23 months old
Benin,BJ,BEN,204,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2020,68,Total,Units,%,Estimated value,Free,,12 to 23 months old
Benin,BJ,BEN,204,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2021,73,Total,Units,%,Estimated value,Free,,12 to 23 months old
Benin,BJ,BEN,204,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2022,73,Total,Units,%,Estimated value,Free,,12 to 23 months old
Bhutan,BT,BTN,64,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2019,26,Total,Units,%,Estimated value,Free,,12 to 23 months old
Bhutan,BT,BTN,64,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2020,90,Total,Units,%,Estimated value,Free,,12 to 23 months old
Bhutan,BT,BTN,64,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2021,95,Total,Units,%,Estimated value,Free,,12 to 23 months old
Bhutan,BT,BTN,64,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2022,97,Total,Units,%,Estimated value,Free,,12 to 23 months old
"Bolivia, Plurinational State of",BO,BOL,68,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2014,56,Total,Units,%,Estimated value,Free,,12 to 23 months old
Bolivia,BO,BOL,68,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2014,56,Total,Units,%,Estimated value,Free,,12 to 23 months old
"Bolivia, Plurinational State of",BO,BOL,68,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2015,86,Total,Units,%,Estimated value,Free,,12 to 23 months old
Bolivia,BO,BOL,68,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2015,86,Total,Units,%,Estimated value,Free,,12 to 23 months old
"Bolivia, Plurinational State of",BO,BOL,68,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2016,87,Total,Units,%,Estimated value,Free,,12 to 23 months old
Bolivia,BO,BOL,68,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2016,87,Total,Units,%,Estimated value,Free,,12 to 23 months old
"Bolivia, Plurinational State of",BO,BOL,68,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2017,83,Total,Units,%,Estimated value,Free,,12 to 23 months old
Bolivia,BO,BOL,68,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2017,83,Total,Units,%,Estimated value,Free,,12 to 23 months old
"Bolivia, Plurinational State of",BO,BOL,68,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2018,83,Total,Units,%,Estimated value,Free,,12 to 23 months old
Bolivia,BO,BOL,68,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2018,83,Total,Units,%,Estimated value,Free,,12 to 23 months old
"Bolivia, Plurinational State of",BO,BOL,68,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2019,75,Total,Units,%,Estimated value,Free,,12 to 23 months old
Bolivia,BO,BOL,68,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2019,75,Total,Units,%,Estimated value,Free,,12 to 23 months old
"Bolivia, Plurinational State of",BO,BOL,68,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2020,68,Total,Units,%,Estimated value,Free,,12 to 23 months old
Bolivia,BO,BOL,68,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2020,68,Total,Units,%,Estimated value,Free,,12 to 23 months old
"Bolivia, Plurinational State of",BO,BOL,68,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2021,70,Total,Units,%,Estimated value,Free,,12 to 23 months old
Bolivia,BO,BOL,68,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2021,70,Total,Units,%,Estimated value,Free,,12 to 23 months old
"Bolivia, Plurinational State of",BO,BOL,68,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2022,69,Total,Units,%,Estimated value,Free,,12 to 23 months old
Bolivia,BO,BOL,68,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2022,69,Total,Units,%,Estimated value,Free,,12 to 23 months old
Botswana,BW,BWA,72,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2012,52,Total,Units,%,Estimated value,Free,,12 to 23 months old
Botswana,BW,BWA,72,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2013,72,Total,Units,%,Estimated value,Free,,12 to 23 months old
Botswana,BW,BWA,72,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2014,95,Total,Units,%,Estimated value,Free,,12 to 23 months old
Botswana,BW,BWA,72,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2015,93,Total,Units,%,Estimated value,Free,,12 to 23 months old
Botswana,BW,BWA,72,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2016,91,Total,Units,%,Estimated value,Free,,12 to 23 months old
Botswana,BW,BWA,72,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2017,89,Total,Units,%,Estimated value,Free,,12 to 23 months old
Botswana,BW,BWA,72,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2018,91,Total,Units,%,Estimated value,Free,,12 to 23 months old
Botswana,BW,BWA,72,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2019,92,Total,Units,%,Estimated value,Free,,12 to 23 months old
Botswana,BW,BWA,72,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2020,90,Total,Units,%,Estimated value,Free,,12 to 23 months old
Botswana,BW,BWA,72,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2021,90,Total,Units,%,Estimated value,Free,,12 to 23 months old
Botswana,BW,BWA,72,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2022,68,Total,Units,%,Estimated value,Free,,12 to 23 months old
Brazil,BR,BRA,76,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2010,24,Total,Units,%,Estimated value,Free,,12 to 23 months old
Brazil,BR,BRA,76,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2011,82,Total,Units,%,Estimated value,Free,,12 to 23 months old
Brazil,BR,BRA,76,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2012,88,Total,Units,%,Estimated value,Free,,12 to 23 months old
Brazil,BR,BRA,76,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2013,94,Total,Units,%,Estimated value,Free,,12 to 23 months old
Brazil,BR,BRA,76,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2014,93,Total,Units,%,Estimated value,Free,,12 to 23 months old
Brazil,BR,BRA,76,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2015,94,Total,Units,%,Estimated value,Free,,12 to 23 months old
Brazil,BR,BRA,76,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2016,84,Total,Units,%,Estimated value,Free,,12 to 23 months old
Brazil,BR,BRA,76,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2017,84,Total,Units,%,Estimated value,Free,,12 to 23 months old
Brazil,BR,BRA,76,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2018,84,Total,Units,%,Estimated value,Free,,12 to 23 months old
Brazil,BR,BRA,76,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2019,84,Total,Units,%,Estimated value,Free,,12 to 23 months old
Brazil,BR,BRA,76,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2020,79,Total,Units,%,Estimated value,Free,,12 to 23 months old
Brazil,BR,BRA,76,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2021,69,Total,Units,%,Estimated value,Free,,12 to 23 months old
Brazil,BR,BRA,76,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2022,81,Total,Units,%,Estimated value,Free,,12 to 23 months old
Bulgaria,BG,BGR,100,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2010,69,Total,Units,%,Estimated value,Free,,12 to 23 months old
Bulgaria,BG,BGR,100,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2011,94,Total,Units,%,Estimated value,Free,,12 to 23 months old
Bulgaria,BG,BGR,100,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2012,94,Total,Units,%,Estimated value,Free,,12 to 23 months old
Bulgaria,BG,BGR,100,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2013,94,Total,Units,%,Estimated value,Free,,12 to 23 months old
Bulgaria,BG,BGR,100,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2014,92,Total,Units,%,Estimated value,Free,,12 to 23 months old
Bulgaria,BG,BGR,100,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2015,90,Total,Units,%,Estimated value,Free,,12 to 23 months old
Bulgaria,BG,BGR,100,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2016,90,Total,Units,%,Estimated value,Free,,12 to 23 months old
Bulgaria,BG,BGR,100,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2017,91,Total,Units,%,Estimated value,Free,,12 to 23 months old
Bulgaria,BG,BGR,100,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2018,88,Total,Units,%,Estimated value,Free,,12 to 23 months old
Bulgaria,BG,BGR,100,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2019,88,Total,Units,%,Estimated value,Free,,12 to 23 months old
Bulgaria,BG,BGR,100,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2020,85,Total,Units,%,Estimated value,Free,,12 to 23 months old
Bulgaria,BG,BGR,100,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2021,86,Total,Units,%,Estimated value,Free,,12 to 23 months old
Bulgaria,BG,BGR,100,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2022,87,Total,Units,%,Estimated value,Free,,12 to 23 months old
Burkina Faso,BF,BFA,854,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2014,91,Total,Units,%,Estimated value,Free,,12 to 23 months old
Burkina Faso,BF,BFA,854,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2015,91,Total,Units,%,Estimated value,Free,,12 to 23 months old
Burkina Faso,BF,BFA,854,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2016,91,Total,Units,%,Estimated value,Free,,12 to 23 months old
Burkina Faso,BF,BFA,854,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2017,91,Total,Units,%,Estimated value,Free,,12 to 23 months old
Burkina Faso,BF,BFA,854,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2018,91,Total,Units,%,Estimated value,Free,,12 to 23 months old
Burkina Faso,BF,BFA,854,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2019,91,Total,Units,%,Estimated value,Free,,12 to 23 months old
Burkina Faso,BF,BFA,854,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2020,91,Total,Units,%,Estimated value,Free,,12 to 23 months old
Burkina Faso,BF,BFA,854,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2021,66,Total,Units,%,Estimated value,Free,,12 to 23 months old
Burkina Faso,BF,BFA,854,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2022,91,Total,Units,%,Estimated value,Free,,12 to 23 months old
Burundi,BI,BDI,108,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2011,14,Total,Units,%,Estimated value,Free,,12 to 23 months old
Burundi,BI,BDI,108,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2012,96,Total,Units,%,Estimated value,Free,,12 to 23 months old
Burundi,BI,BDI,108,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2013,96,Total,Units,%,Estimated value,Free,,12 to 23 months old
Burundi,BI,BDI,108,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2014,95,Total,Units,%,Estimated value,Free,,12 to 23 months old
Burundi,BI,BDI,108,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2015,94,Total,Units,%,Estimated value,Free,,12 to 23 months old
Burundi,BI,BDI,108,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2016,94,Total,Units,%,Estimated value,Free,,12 to 23 months old
Burundi,BI,BDI,108,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2017,91,Total,Units,%,Estimated value,Free,,12 to 23 months old
Burundi,BI,BDI,108,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2018,90,Total,Units,%,Estimated value,Free,,12 to 23 months old
Burundi,BI,BDI,108,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2019,93,Total,Units,%,Estimated value,Free,,12 to 23 months old
Burundi,BI,BDI,108,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2020,93,Total,Units,%,Estimated value,Free,,12 to 23 months old
Burundi,BI,BDI,108,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2021,94,Total,Units,%,Estimated value,Free,,12 to 23 months old
Burundi,BI,BDI,108,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2022,91,Total,Units,%,Estimated value,Free,,12 to 23 months old
Cambodia,KH,KHM,116,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2015,68,Total,Units,%,Estimated value,Free,,12 to 23 months old
Cambodia,KH,KHM,116,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2016,87,Total,Units,%,Estimated value,Free,,12 to 23 months old
Cambodia,KH,KHM,116,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2017,81,Total,Units,%,Estimated value,Free,,12 to 23 months old
Cambodia,KH,KHM,116,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2018,83,Total,Units,%,Estimated value,Free,,12 to 23 months old
Cambodia,KH,KHM,116,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2019,88,Total,Units,%,Estimated value,Free,,12 to 23 months old
Cambodia,KH,KHM,116,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2020,86,Total,Units,%,Estimated value,Free,,12 to 23 months old
Cambodia,KH,KHM,116,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2021,86,Total,Units,%,Estimated value,Free,,12 to 23 months old
Cambodia,KH,KHM,116,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2022,84,Total,Units,%,Estimated value,Free,,12 to 23 months old
Cameroon,CM,CMR,120,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2011,23,Total,Units,%,Estimated value,Free,,12 to 23 months old
Cameroon,CM,CMR,120,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2012,84,Total,Units,%,Estimated value,Free,,12 to 23 months old
Cameroon,CM,CMR,120,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2013,88,Total,Units,%,Estimated value,Free,,12 to 23 months old
Cameroon,CM,CMR,120,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2014,83,Total,Units,%,Estimated value,Free,,12 to 23 months old
Cameroon,CM,CMR,120,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2015,77,Total,Units,%,Estimated value,Free,,12 to 23 months old
Cameroon,CM,CMR,120,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2016,72,Total,Units,%,Estimated value,Free,,12 to 23 months old
Cameroon,CM,CMR,120,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2017,72,Total,Units,%,Estimated value,Free,,12 to 23 months old
Cameroon,CM,CMR,120,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2018,67,Total,Units,%,Estimated value,Free,,12 to 23 months old
Cameroon,CM,CMR,120,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2019,67,Total,Units,%,Estimated value,Free,,12 to 23 months old
Cameroon,CM,CMR,120,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2020,69,Total,Units,%,Estimated value,Free,,12 to 23 months old
Cameroon,CM,CMR,120,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2021,67,Total,Units,%,Estimated value,Free,,12 to 23 months old
Cameroon,CM,CMR,120,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2022,67,Total,Units,%,Estimated value,Free,,12 to 23 months old
Canada,CA,CAN,124,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2008,42,Total,Units,%,Estimated value,Free,,12 to 23 months old
Canada,CA,CAN,124,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2009,50,Total,Units,%,Estimated value,Free,,12 to 23 months old
Canada,CA,CAN,124,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2010,58,Total,Units,%,Estimated value,Free,,12 to 23 months old
Canada,CA,CAN,124,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2011,66,Total,Units,%,Estimated value,Free,,12 to 23 months old
Canada,CA,CAN,124,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2012,73,Total,Units,%,Estimated value,Free,,12 to 23 months old
Canada,CA,CAN,124,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2013,79,Total,Units,%,Estimated value,Free,,12 to 23 months old
Canada,CA,CAN,124,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2014,79,Total,Units,%,Estimated value,Free,,12 to 23 months old
Canada,CA,CAN,124,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2015,80,Total,Units,%,Estimated value,Free,,12 to 23 months old
Canada,CA,CAN,124,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2016,80,Total,Units,%,Estimated value,Free,,12 to 23 months old
Canada,CA,CAN,124,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2017,81,Total,Units,%,Estimated value,Free,,12 to 23 months old
Canada,CA,CAN,124,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2018,81,Total,Units,%,Estimated value,Free,,12 to 23 months old
Canada,CA,CAN,124,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2019,84,Total,Units,%,Estimated value,Free,,12 to 23 months old
Canada,CA,CAN,124,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2020,84,Total,Units,%,Estimated value,Free,,12 to 23 months old
Canada,CA,CAN,124,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2021,84,Total,Units,%,Estimated value,Free,,12 to 23 months old
Canada,CA,CAN,124,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2022,85,Total,Units,%,Estimated value,Free,,12 to 23 months old
Central African Republic,CF,CAF,140,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2011,8,Total,Units,%,Estimated value,Free,,12 to 23 months old
Central African Republic,CF,CAF,140,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2012,47,Total,Units,%,Estimated value,Free,,12 to 23 months old
Central African Republic,CF,CAF,140,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2013,23,Total,Units,%,Estimated value,Free,,12 to 23 months old
Central African Republic,CF,CAF,140,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2014,45,Total,Units,%,Estimated value,Free,,12 to 23 months old
Central African Republic,CF,CAF,140,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2015,44,Total,Units,%,Estimated value,Free,,12 to 23 months old
Central African Republic,CF,CAF,140,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2016,43,Total,Units,%,Estimated value,Free,,12 to 23 months old
Central African Republic,CF,CAF,140,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2017,40,Total,Units,%,Estimated value,Free,,12 to 23 months old
Central African Republic,CF,CAF,140,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2018,40,Total,Units,%,Estimated value,Free,,12 to 23 months old
Central African Republic,CF,CAF,140,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2019,40,Total,Units,%,Estimated value,Free,,12 to 23 months old
Central African Republic,CF,CAF,140,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2020,40,Total,Units,%,Estimated value,Free,,12 to 23 months old
Central African Republic,CF,CAF,140,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2021,40,Total,Units,%,Estimated value,Free,,12 to 23 months old
Central African Republic,CF,CAF,140,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2022,40,Total,Units,%,Estimated value,Free,,12 to 23 months old
Chile,CL,CHL,152,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2011,54,Total,Units,%,Estimated value,Free,,12 to 23 months old
Chile,CL,CHL,152,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2012,82,Total,Units,%,Estimated value,Free,,12 to 23 months old
Chile,CL,CHL,152,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2013,79,Total,Units,%,Estimated value,Free,,12 to 23 months old
Chile,CL,CHL,152,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2014,92,Total,Units,%,Estimated value,Free,,12 to 23 months old
Chile,CL,CHL,152,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2015,90,Total,Units,%,Estimated value,Free,,12 to 23 months old
Chile,CL,CHL,152,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2016,93,Total,Units,%,Estimated value,Free,,12 to 23 months old
Chile,CL,CHL,152,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2017,93,Total,Units,%,Estimated value,Free,,12 to 23 months old
Chile,CL,CHL,152,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2018,93,Total,Units,%,Estimated value,Free,,12 to 23 months old
Chile,CL,CHL,152,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2019,95,Total,Units,%,Estimated value,Free,,12 to 23 months old
Chile,CL,CHL,152,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2020,89,Total,Units,%,Estimated value,Free,,12 to 23 months old
Chile,CL,CHL,152,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2021,92,Total,Units,%,Estimated value,Free,,12 to 23 months old
Chile,CL,CHL,152,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2022,93,Total,Units,%,Estimated value,Free,,12 to 23 months old
Colombia,CO,COL,170,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2010,22,Total,Units,%,Estimated value,Free,,12 to 23 months old
Colombia,CO,COL,170,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2011,46,Total,Units,%,Estimated value,Free,,12 to 23 months old
Colombia,CO,COL,170,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2012,84,Total,Units,%,Estimated value,Free,,12 to 23 months old
Colombia,CO,COL,170,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2013,87,Total,Units,%,Estimated value,Free,,12 to 23 months old
Colombia,CO,COL,170,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2014,89,Total,Units,%,Estimated value,Free,,12 to 23 months old
Colombia,CO,COL,170,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2015,91,Total,Units,%,Estimated value,Free,,12 to 23 months old
Colombia,CO,COL,170,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2016,89,Total,Units,%,Estimated value,Free,,12 to 23 months old
Colombia,CO,COL,170,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2017,91,Total,Units,%,Estimated value,Free,,12 to 23 months old
Colombia,CO,COL,170,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2018,94,Total,Units,%,Estimated value,Free,,12 to 23 months old
Colombia,CO,COL,170,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2019,93,Total,Units,%,Estimated value,Free,,12 to 23 months old
Colombia,CO,COL,170,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2020,89,Total,Units,%,Estimated value,Free,,12 to 23 months old
Colombia,CO,COL,170,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2021,84,Total,Units,%,Estimated value,Free,,12 to 23 months old
Colombia,CO,COL,170,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2022,85,Total,Units,%,Estimated value,Free,,12 to 23 months old
Congo,CG,COG,178,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2012,10,Total,Units,%,Estimated value,Free,,12 to 23 months old
Congo,CG,COG,178,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2013,85,Total,Units,%,Estimated value,Free,,12 to 23 months old
Congo,CG,COG,178,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2014,85,Total,Units,%,Estimated value,Free,,12 to 23 months old
Congo,CG,COG,178,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2015,80,Total,Units,%,Estimated value,Free,,12 to 23 months old
Congo,CG,COG,178,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2016,67,Total,Units,%,Estimated value,Free,,12 to 23 months old
Congo,CG,COG,178,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2017,66,Total,Units,%,Estimated value,Free,,12 to 23 months old
Congo,CG,COG,178,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2018,73,Total,Units,%,Estimated value,Free,,12 to 23 months old
Congo,CG,COG,178,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2019,68,Total,Units,%,Estimated value,Free,,12 to 23 months old
Congo,CG,COG,178,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2020,71,Total,Units,%,Estimated value,Free,,12 to 23 months old
Congo,CG,COG,178,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2021,75,Total,Units,%,Estimated value,Free,,12 to 23 months old
Congo,CG,COG,178,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2022,76,Total,Units,%,Estimated value,Free,,12 to 23 months old
Costa Rica,CR,CRI,188,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2009,48,Total,Units,%,Estimated value,Free,,12 to 23 months old
Costa Rica,CR,CRI,188,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2010,94,Total,Units,%,Estimated value,Free,,12 to 23 months old
Costa Rica,CR,CRI,188,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2011,68,Total,Units,%,Estimated value,Free,,12 to 23 months old
Costa Rica,CR,CRI,188,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2012,89,Total,Units,%,Estimated value,Free,,12 to 23 months old
Costa Rica,CR,CRI,188,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2013,94,Total,Units,%,Estimated value,Free,,12 to 23 months old
Costa Rica,CR,CRI,188,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2014,83,Total,Units,%,Estimated value,Free,,12 to 23 months old
Costa Rica,CR,CRI,188,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2015,94,Total,Units,%,Estimated value,Free,,12 to 23 months old
Costa Rica,CR,CRI,188,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2016,94,Total,Units,%,Estimated value,Free,,12 to 23 months old
Costa Rica,CR,CRI,188,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2017,96,Total,Units,%,Estimated value,Free,,12 to 23 months old
Costa Rica,CR,CRI,188,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2018,96,Total,Units,%,Estimated value,Free,,12 to 23 months old
Costa Rica,CR,CRI,188,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2019,95,Total,Units,%,Estimated value,Free,,12 to 23 months old
Costa Rica,CR,CRI,188,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2020,94,Total,Units,%,Estimated value,Free,,12 to 23 months old
Costa Rica,CR,CRI,188,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2021,87,Total,Units,%,Estimated value,Free,,12 to 23 months old
Costa Rica,CR,CRI,188,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2022,92,Total,Units,%,Estimated value,Free,,12 to 23 months old
Croatia,HR,HRV,191,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2021,75,Total,Units,%,Estimated value,Free,,12 to 23 months old
Croatia,HR,HRV,191,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2022,90,Total,Units,%,Estimated value,Free,,12 to 23 months old
Cyprus,CY,CYP,196,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2015,81,Total,Units,%,Estimated value,Free,,12 to 23 months old
Cyprus,CY,CYP,196,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2016,81,Total,Units,%,Estimated value,Free,,12 to 23 months old
Cyprus,CY,CYP,196,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2017,81,Total,Units,%,Estimated value,Free,,12 to 23 months old
Cyprus,CY,CYP,196,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2018,81,Total,Units,%,Estimated value,Free,,12 to 23 months old
Cyprus,CY,CYP,196,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2019,81,Total,Units,%,Estimated value,Free,,12 to 23 months old
Cyprus,CY,CYP,196,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2020,81,Total,Units,%,Estimated value,Free,,12 to 23 months old
Cyprus,CY,CYP,196,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2021,81,Total,Units,%,Estimated value,Free,,12 to 23 months old
Cyprus,CY,CYP,196,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2022,81,Total,Units,%,Estimated value,Free,,12 to 23 months old
Côte d'Ivoire,CI,CIV,384,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2014,2,Total,Units,%,Estimated value,Free,,12 to 23 months old
Ivory Coast,CI,CIV,384,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2014,2,Total,Units,%,Estimated value,Free,,12 to 23 months old
Côte d'Ivoire,CI,CIV,384,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2015,70,Total,Units,%,Estimated value,Free,,12 to 23 months old
Ivory Coast,CI,CIV,384,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2015,70,Total,Units,%,Estimated value,Free,,12 to 23 months old
Côte d'Ivoire,CI,CIV,384,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2016,80,Total,Units,%,Estimated value,Free,,12 to 23 months old
Ivory Coast,CI,CIV,384,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2016,80,Total,Units,%,Estimated value,Free,,12 to 23 months old
Côte d'Ivoire,CI,CIV,384,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2017,81,Total,Units,%,Estimated value,Free,,12 to 23 months old
Ivory Coast,CI,CIV,384,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2017,81,Total,Units,%,Estimated value,Free,,12 to 23 months old
Côte d'Ivoire,CI,CIV,384,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2018,80,Total,Units,%,Estimated value,Free,,12 to 23 months old
Ivory Coast,CI,CIV,384,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2018,80,Total,Units,%,Estimated value,Free,,12 to 23 months old
Côte d'Ivoire,CI,CIV,384,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2019,74,Total,Units,%,Estimated value,Free,,12 to 23 months old
Ivory Coast,CI,CIV,384,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2019,74,Total,Units,%,Estimated value,Free,,12 to 23 months old
Côte d'Ivoire,CI,CIV,384,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2020,64,Total,Units,%,Estimated value,Free,,12 to 23 months old
Ivory Coast,CI,CIV,384,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2020,64,Total,Units,%,Estimated value,Free,,12 to 23 months old
Côte d'Ivoire,CI,CIV,384,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2021,57,Total,Units,%,Estimated value,Free,,12 to 23 months old
Ivory Coast,CI,CIV,384,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2021,57,Total,Units,%,Estimated value,Free,,12 to 23 months old
Côte d'Ivoire,CI,CIV,384,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2022,61,Total,Units,%,Estimated value,Free,,12 to 23 months old
Ivory Coast,CI,CIV,384,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2022,61,Total,Units,%,Estimated value,Free,,12 to 23 months old
"Congo, the Democratic Republic of the",CD,COD,180,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2011,3,Total,Units,%,Estimated value,Free,,12 to 23 months old
"Congo, the Democratic Republic of the",CD,COD,180,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2012,23,Total,Units,%,Estimated value,Free,,12 to 23 months old
"Congo, the Democratic Republic of the",CD,COD,180,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2013,34,Total,Units,%,Estimated value,Free,,12 to 23 months old
"Congo, the Democratic Republic of the",CD,COD,180,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2014,48,Total,Units,%,Estimated value,Free,,12 to 23 months old
"Congo, the Democratic Republic of the",CD,COD,180,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2015,64,Total,Units,%,Estimated value,Free,,12 to 23 months old
"Congo, the Democratic Republic of the",CD,COD,180,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2016,66,Total,Units,%,Estimated value,Free,,12 to 23 months old
"Congo, the Democratic Republic of the",CD,COD,180,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2017,69,Total,Units,%,Estimated value,Free,,12 to 23 months old
"Congo, the Democratic Republic of the",CD,COD,180,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2018,70,Total,Units,%,Estimated value,Free,,12 to 23 months old
"Congo, the Democratic Republic of the",CD,COD,180,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2019,72,Total,Units,%,Estimated value,Free,,12 to 23 months old
"Congo, the Democratic Republic of the",CD,COD,180,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2020,69,Total,Units,%,Estimated value,Free,,12 to 23 months old
"Congo, the Democratic Republic of the",CD,COD,180,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2021,63,Total,Units,%,Estimated value,Free,,12 to 23 months old
"Congo, the Democratic Republic of the",CD,COD,180,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2022,64,Total,Units,%,Estimated value,Free,,12 to 23 months old
Denmark,DK,DNK,208,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2009,86,Total,Units,%,Estimated value,Free,,12 to 23 months old
Denmark,DK,DNK,208,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2010,88,Total,Units,%,Estimated value,Free,,12 to 23 months old
Denmark,DK,DNK,208,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2011,90,Total,Units,%,Estimated value,Free,,12 to 23 months old
Denmark,DK,DNK,208,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2012,93,Total,Units,%,Estimated value,Free,,12 to 23 months old
Denmark,DK,DNK,208,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2013,90,Total,Units,%,Estimated value,Free,,12 to 23 months old
Denmark,DK,DNK,208,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2014,93,Total,Units,%,Estimated value,Free,,12 to 23 months old
Denmark,DK,DNK,208,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2015,91,Total,Units,%,Estimated value,Free,,12 to 23 months old
Denmark,DK,DNK,208,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2016,94,Total,Units,%,Estimated value,Free,,12 to 23 months old
Denmark,DK,DNK,208,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2017,97,Total,Units,%,Estimated value,Free,,12 to 23 months old
Denmark,DK,DNK,208,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2018,96,Total,Units,%,Estimated value,Free,,12 to 23 months old
Denmark,DK,DNK,208,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2019,97,Total,Units,%,Estimated value,Free,,12 to 23 months old
Denmark,DK,DNK,208,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2020,96,Total,Units,%,Estimated value,Free,,12 to 23 months old
Denmark,DK,DNK,208,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2021,96,Total,Units,%,Estimated value,Free,,12 to 23 months old
Denmark,DK,DNK,208,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2022,96,Total,Units,%,Estimated value,Free,,12 to 23 months old
Djibouti,DJ,DJI,262,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2013,82,Total,Units,%,Estimated value,Free,,12 to 23 months old
Djibouti,DJ,DJI,262,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2014,78,Total,Units,%,Estimated value,Free,,12 to 23 months old
Djibouti,DJ,DJI,262,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2015,82,Total,Units,%,Estimated value,Free,,12 to 23 months old
Djibouti,DJ,DJI,262,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2016,68,Total,Units,%,Estimated value,Free,,12 to 23 months old
Djibouti,DJ,DJI,262,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2017,76,Total,Units,%,Estimated value,Free,,12 to 23 months old
Djibouti,DJ,DJI,262,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2018,84,Total,Units,%,Estimated value,Free,,12 to 23 months old
Djibouti,DJ,DJI,262,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2019,85,Total,Units,%,Estimated value,Free,,12 to 23 months old
Djibouti,DJ,DJI,262,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2020,70,Total,Units,%,Estimated value,Free,,12 to 23 months old
Djibouti,DJ,DJI,262,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2021,59,Total,Units,%,Estimated value,Free,,12 to 23 months old
Djibouti,DJ,DJI,262,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2022,59,Total,Units,%,Estimated value,Free,,12 to 23 months old
Dominican Republic,DO,DOM,214,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2014,27,Total,Units,%,Estimated value,Free,,12 to 23 months old
Dominican Republic,DO,DOM,214,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2015,22,Total,Units,%,Estimated value,Free,,12 to 23 months old
Dominican Republic,DO,DOM,214,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2016,30,Total,Units,%,Estimated value,Free,,12 to 23 months old
Dominican Republic,DO,DOM,214,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2017,64,Total,Units,%,Estimated value,Free,,12 to 23 months old
Dominican Republic,DO,DOM,214,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2018,66,Total,Units,%,Estimated value,Free,,12 to 23 months old
Dominican Republic,DO,DOM,214,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2019,67,Total,Units,%,Estimated value,Free,,12 to 23 months old
Dominican Republic,DO,DOM,214,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2020,69,Total,Units,%,Estimated value,Free,,12 to 23 months old
Dominican Republic,DO,DOM,214,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2021,76,Total,Units,%,Estimated value,Free,,12 to 23 months old
Dominican Republic,DO,DOM,214,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2022,73,Total,Units,%,Estimated value,Free,,12 to 23 months old
Ecuador,EC,ECU,218,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2010,17,Total,Units,%,Estimated value,Free,,12 to 23 months old
Ecuador,EC,ECU,218,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2011,71,Total,Units,%,Estimated value,Free,,12 to 23 months old
Ecuador,EC,ECU,218,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2012,94,Total,Units,%,Estimated value,Free,,12 to 23 months old
Ecuador,EC,ECU,218,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2013,90,Total,Units,%,Estimated value,Free,,12 to 23 months old
Ecuador,EC,ECU,218,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2014,86,Total,Units,%,Estimated value,Free,,12 to 23 months old
Ecuador,EC,ECU,218,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2015,81,Total,Units,%,Estimated value,Free,,12 to 23 months old
Ecuador,EC,ECU,218,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2016,84,Total,Units,%,Estimated value,Free,,12 to 23 months old
Ecuador,EC,ECU,218,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2017,84,Total,Units,%,Estimated value,Free,,12 to 23 months old
Ecuador,EC,ECU,218,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2018,85,Total,Units,%,Estimated value,Free,,12 to 23 months old
Ecuador,EC,ECU,218,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2019,83,Total,Units,%,Estimated value,Free,,12 to 23 months old
Ecuador,EC,ECU,218,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2020,76,Total,Units,%,Estimated value,Free,,12 to 23 months old
Ecuador,EC,ECU,218,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2021,62,Total,Units,%,Estimated value,Free,,12 to 23 months old
Ecuador,EC,ECU,218,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2022,71,Total,Units,%,Estimated value,Free,,12 to 23 months old
El Salvador,SV,SLV,222,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2010,66,Total,Units,%,Estimated value,Free,,12 to 23 months old
El Salvador,SV,SLV,222,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2011,95,Total,Units,%,Estimated value,Free,,12 to 23 months old
El Salvador,SV,SLV,222,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2012,94,Total,Units,%,Estimated value,Free,,12 to 23 months old
El Salvador,SV,SLV,222,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2013,91,Total,Units,%,Estimated value,Free,,12 to 23 months old
El Salvador,SV,SLV,222,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2014,88,Total,Units,%,Estimated value,Free,,12 to 23 months old
El Salvador,SV,SLV,222,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2015,99,Total,Units,%,Estimated value,Free,,12 to 23 months old
El Salvador,SV,SLV,222,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2016,96,Total,Units,%,Estimated value,Free,,12 to 23 months old
El Salvador,SV,SLV,222,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2017,95,Total,Units,%,Estimated value,Free,,12 to 23 months old
El Salvador,SV,SLV,222,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2018,87,Total,Units,%,Estimated value,Free,,12 to 23 months old
El Salvador,SV,SLV,222,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2019,85,Total,Units,%,Estimated value,Free,,12 to 23 months old
El Salvador,SV,SLV,222,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2020,81,Total,Units,%,Estimated value,Free,,12 to 23 months old
El Salvador,SV,SLV,222,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2021,92,Total,Units,%,Estimated value,Free,,12 to 23 months old
El Salvador,SV,SLV,222,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2022,73,Total,Units,%,Estimated value,Free,,12 to 23 months old
Eritrea,ER,ERI,232,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2016,95,Total,Units,%,Estimated value,Free,,12 to 23 months old
Eritrea,ER,ERI,232,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2017,95,Total,Units,%,Estimated value,Free,,12 to 23 months old
Eritrea,ER,ERI,232,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2018,95,Total,Units,%,Estimated value,Free,,12 to 23 months old
Eritrea,ER,ERI,232,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2019,95,Total,Units,%,Estimated value,Free,,12 to 23 months old
Eritrea,ER,ERI,232,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2020,95,Total,Units,%,Estimated value,Free,,12 to 23 months old
Eritrea,ER,ERI,232,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2021,95,Total,Units,%,Estimated value,Free,,12 to 23 months old
Eritrea,ER,ERI,232,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2022,95,Total,Units,%,Estimated value,Free,,12 to 23 months old
Swaziland,SZ,SWZ,748,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2014,67,Total,Units,%,Estimated value,Free,,12 to 23 months old
Swaziland,SZ,SWZ,748,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2015,90,Total,Units,%,Estimated value,Free,,12 to 23 months old
Swaziland,SZ,SWZ,748,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2016,90,Total,Units,%,Estimated value,Free,,12 to 23 months old
Swaziland,SZ,SWZ,748,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2017,87,Total,Units,%,Estimated value,Free,,12 to 23 months old
Swaziland,SZ,SWZ,748,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2018,88,Total,Units,%,Estimated value,Free,,12 to 23 months old
Swaziland,SZ,SWZ,748,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2019,87,Total,Units,%,Estimated value,Free,,12 to 23 months old
Swaziland,SZ,SWZ,748,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2020,83,Total,Units,%,Estimated value,Free,,12 to 23 months old
Swaziland,SZ,SWZ,748,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2021,63,Total,Units,%,Estimated value,Free,,12 to 23 months old
Swaziland,SZ,SWZ,748,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2022,96,Total,Units,%,Estimated value,Free,,12 to 23 months old
Ethiopia,ET,ETH,231,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2011,12,Total,Units,%,Estimated value,Free,,12 to 23 months old
Ethiopia,ET,ETH,231,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2012,30,Total,Units,%,Estimated value,Free,,12 to 23 months old
Ethiopia,ET,ETH,231,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2013,48,Total,Units,%,Estimated value,Free,,12 to 23 months old
Ethiopia,ET,ETH,231,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2014,54,Total,Units,%,Estimated value,Free,,12 to 23 months old
Ethiopia,ET,ETH,231,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2015,57,Total,Units,%,Estimated value,Free,,12 to 23 months old
Ethiopia,ET,ETH,231,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2016,61,Total,Units,%,Estimated value,Free,,12 to 23 months old
Ethiopia,ET,ETH,231,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2017,64,Total,Units,%,Estimated value,Free,,12 to 23 months old
Ethiopia,ET,ETH,231,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2018,63,Total,Units,%,Estimated value,Free,,12 to 23 months old
Ethiopia,ET,ETH,231,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2019,64,Total,Units,%,Estimated value,Free,,12 to 23 months old
Ethiopia,ET,ETH,231,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2020,67,Total,Units,%,Estimated value,Free,,12 to 23 months old
Ethiopia,ET,ETH,231,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2021,61,Total,Units,%,Estimated value,Free,,12 to 23 months old
Ethiopia,ET,ETH,231,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2022,61,Total,Units,%,Estimated value,Free,,12 to 23 months old
Fiji,FJ,FJI,242,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2013,87,Total,Units,%,Estimated value,Free,,12 to 23 months old
Fiji,FJ,FJI,242,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2014,99,Total,Units,%,Estimated value,Free,,12 to 23 months old
Fiji,FJ,FJI,242,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2015,99,Total,Units,%,Estimated value,Free,,12 to 23 months old
Fiji,FJ,FJI,242,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2016,93,Total,Units,%,Estimated value,Free,,12 to 23 months old
Fiji,FJ,FJI,242,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2017,90,Total,Units,%,Estimated value,Free,,12 to 23 months old
Fiji,FJ,FJI,242,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2018,94,Total,Units,%,Estimated value,Free,,12 to 23 months old
Fiji,FJ,FJI,242,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2019,96,Total,Units,%,Estimated value,Free,,12 to 23 months old
Fiji,FJ,FJI,242,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2020,98,Total,Units,%,Estimated value,Free,,12 to 23 months old
Fiji,FJ,FJI,242,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2021,99,Total,Units,%,Estimated value,Free,,12 to 23 months old
Fiji,FJ,FJI,242,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2022,99,Total,Units,%,Estimated value,Free,,12 to 23 months old
Finland,FI,FIN,246,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2010,92,Total,Units,%,Estimated value,Free,,12 to 23 months old
Finland,FI,FIN,246,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2011,92,Total,Units,%,Estimated value,Free,,12 to 23 months old
Finland,FI,FIN,246,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2012,92,Total,Units,%,Estimated value,Free,,12 to 23 months old
Finland,FI,FIN,246,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2013,92,Total,Units,%,Estimated value,Free,,12 to 23 months old
Finland,FI,FIN,246,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2014,92,Total,Units,%,Estimated value,Free,,12 to 23 months old
Finland,FI,FIN,246,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2015,92,Total,Units,%,Estimated value,Free,,12 to 23 months old
Finland,FI,FIN,246,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2016,87,Total,Units,%,Estimated value,Free,,12 to 23 months old
Finland,FI,FIN,246,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2017,85,Total,Units,%,Estimated value,Free,,12 to 23 months old
Finland,FI,FIN,246,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2018,88,Total,Units,%,Estimated value,Free,,12 to 23 months old
Finland,FI,FIN,246,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2019,89,Total,Units,%,Estimated value,Free,,12 to 23 months old
Finland,FI,FIN,246,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2020,86,Total,Units,%,Estimated value,Free,,12 to 23 months old
Finland,FI,FIN,246,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2021,82,Total,Units,%,Estimated value,Free,,12 to 23 months old
Finland,FI,FIN,246,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2022,87,Total,Units,%,Estimated value,Free,,12 to 23 months old
France,FR,FRA,250,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2010,89,Total,Units,%,Estimated value,Free,,12 to 23 months old
France,FR,FRA,250,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2011,89,Total,Units,%,Estimated value,Free,,12 to 23 months old
France,FR,FRA,250,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2012,89,Total,Units,%,Estimated value,Free,,12 to 23 months old
France,FR,FRA,250,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2013,89,Total,Units,%,Estimated value,Free,,12 to 23 months old
France,FR,FRA,250,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2014,89,Total,Units,%,Estimated value,Free,,12 to 23 months old
France,FR,FRA,250,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2015,91,Total,Units,%,Estimated value,Free,,12 to 23 months old
France,FR,FRA,250,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2016,92,Total,Units,%,Estimated value,Free,,12 to 23 months old
France,FR,FRA,250,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2017,92,Total,Units,%,Estimated value,Free,,12 to 23 months old
France,FR,FRA,250,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2018,92,Total,Units,%,Estimated value,Free,,12 to 23 months old
France,FR,FRA,250,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2019,92,Total,Units,%,Estimated value,Free,,12 to 23 months old
France,FR,FRA,250,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2020,95,Total,Units,%,Estimated value,Free,,12 to 23 months old
France,FR,FRA,250,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2021,95,Total,Units,%,Estimated value,Free,,12 to 23 months old
France,FR,FRA,250,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2022,95,Total,Units,%,Estimated value,Free,,12 to 23 months old
Gambia,GM,GMB,270,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2010,99,Total,Units,%,Estimated value,Free,,12 to 23 months old
Gambia,GM,GMB,270,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2011,95,Total,Units,%,Estimated value,Free,,12 to 23 months old
Gambia,GM,GMB,270,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2012,98,Total,Units,%,Estimated value,Free,,12 to 23 months old
Gambia,GM,GMB,270,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2013,96,Total,Units,%,Estimated value,Free,,12 to 23 months old
Gambia,GM,GMB,270,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2014,96,Total,Units,%,Estimated value,Free,,12 to 23 months old
Gambia,GM,GMB,270,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2015,97,Total,Units,%,Estimated value,Free,,12 to 23 months old
Gambia,GM,GMB,270,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2016,95,Total,Units,%,Estimated value,Free,,12 to 23 months old
Gambia,GM,GMB,270,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2017,90,Total,Units,%,Estimated value,Free,,12 to 23 months old
Gambia,GM,GMB,270,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2018,93,Total,Units,%,Estimated value,Free,,12 to 23 months old
Gambia,GM,GMB,270,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2019,87,Total,Units,%,Estimated value,Free,,12 to 23 months old
Gambia,GM,GMB,270,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2020,83,Total,Units,%,Estimated value,Free,,12 to 23 months old
Gambia,GM,GMB,270,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2021,78,Total,Units,%,Estimated value,Free,,12 to 23 months old
Gambia,GM,GMB,270,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2022,75,Total,Units,%,Estimated value,Free,,12 to 23 months old
Georgia,GE,GEO,268,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2015,16,Total,Units,%,Estimated value,Free,,12 to 23 months old
Georgia,GE,GEO,268,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2016,75,Total,Units,%,Estimated value,Free,,12 to 23 months old
Georgia,GE,GEO,268,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2017,80,Total,Units,%,Estimated value,Free,,12 to 23 months old
Georgia,GE,GEO,268,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2018,81,Total,Units,%,Estimated value,Free,,12 to 23 months old
Georgia,GE,GEO,268,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2019,84,Total,Units,%,Estimated value,Free,,12 to 23 months old
Georgia,GE,GEO,268,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2020,82,Total,Units,%,Estimated value,Free,,12 to 23 months old
Georgia,GE,GEO,268,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2021,82,Total,Units,%,Estimated value,Free,,12 to 23 months old
Georgia,GE,GEO,268,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2022,79,Total,Units,%,Estimated value,Free,,12 to 23 months old
Germany,DE,DEU,276,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2008,68,Total,Units,%,Estimated value,Free,,12 to 23 months old
Germany,DE,DEU,276,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2009,84,Total,Units,%,Estimated value,Free,,12 to 23 months old
Germany,DE,DEU,276,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2010,85,Total,Units,%,Estimated value,Free,,12 to 23 months old
Germany,DE,DEU,276,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2011,86,Total,Units,%,Estimated value,Free,,12 to 23 months old
Germany,DE,DEU,276,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2012,84,Total,Units,%,Estimated value,Free,,12 to 23 months old
Germany,DE,DEU,276,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2013,84,Total,Units,%,Estimated value,Free,,12 to 23 months old
Germany,DE,DEU,276,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2014,82,Total,Units,%,Estimated value,Free,,12 to 23 months old
Germany,DE,DEU,276,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2015,83,Total,Units,%,Estimated value,Free,,12 to 23 months old
Germany,DE,DEU,276,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2016,82,Total,Units,%,Estimated value,Free,,12 to 23 months old
Germany,DE,DEU,276,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2017,82,Total,Units,%,Estimated value,Free,,12 to 23 months old
Germany,DE,DEU,276,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2018,82,Total,Units,%,Estimated value,Free,,12 to 23 months old
Germany,DE,DEU,276,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2019,82,Total,Units,%,Estimated value,Free,,12 to 23 months old
Germany,DE,DEU,276,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2020,82,Total,Units,%,Estimated value,Free,,12 to 23 months old
Germany,DE,DEU,276,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2021,82,Total,Units,%,Estimated value,Free,,12 to 23 months old
Germany,DE,DEU,276,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2022,82,Total,Units,%,Estimated value,Free,,12 to 23 months old
Ghana,GH,GHA,288,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2012,43,Total,Units,%,Estimated value,Free,,12 to 23 months old
Ghana,GH,GHA,288,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2013,89,Total,Units,%,Estimated value,Free,,12 to 23 months old
Ghana,GH,GHA,288,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2014,99,Total,Units,%,Estimated value,Free,,12 to 23 months old
Ghana,GH,GHA,288,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2015,88,Total,Units,%,Estimated value,Free,,12 to 23 months old
Ghana,GH,GHA,288,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2016,93,Total,Units,%,Estimated value,Free,,12 to 23 months old
Ghana,GH,GHA,288,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2017,99,Total,Units,%,Estimated value,Free,,12 to 23 months old
Ghana,GH,GHA,288,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2018,96,Total,Units,%,Estimated value,Free,,12 to 23 months old
Ghana,GH,GHA,288,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2019,97,Total,Units,%,Estimated value,Free,,12 to 23 months old
Ghana,GH,GHA,288,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2020,95,Total,Units,%,Estimated value,Free,,12 to 23 months old
Ghana,GH,GHA,288,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2021,98,Total,Units,%,Estimated value,Free,,12 to 23 months old
Ghana,GH,GHA,288,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2022,99,Total,Units,%,Estimated value,Free,,12 to 23 months old
Greece,GR,GRC,300,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2012,32,Total,Units,%,Estimated value,Free,,12 to 23 months old
Greece,GR,GRC,300,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2013,32,Total,Units,%,Estimated value,Free,,12 to 23 months old
Greece,GR,GRC,300,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2014,96,Total,Units,%,Estimated value,Free,,12 to 23 months old
Greece,GR,GRC,300,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2015,96,Total,Units,%,Estimated value,Free,,12 to 23 months old
Greece,GR,GRC,300,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2016,96,Total,Units,%,Estimated value,Free,,12 to 23 months old
Greece,GR,GRC,300,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2017,96,Total,Units,%,Estimated value,Free,,12 to 23 months old
Greece,GR,GRC,300,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2018,96,Total,Units,%,Estimated value,Free,,12 to 23 months old
Greece,GR,GRC,300,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2019,96,Total,Units,%,Estimated value,Free,,12 to 23 months old
Greece,GR,GRC,300,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2020,96,Total,Units,%,Estimated value,Free,,12 to 23 months old
Greece,GR,GRC,300,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2021,96,Total,Units,%,Estimated value,Free,,12 to 23 months old
Greece,GR,GRC,300,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2022,96,Total,Units,%,Estimated value,Free,,12 to 23 months old
Guatemala,GT,GTM,320,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2013,72,Total,Units,%,Estimated value,Free,,12 to 23 months old
Guatemala,GT,GTM,320,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2014,62,Total,Units,%,Estimated value,Free,,12 to 23 months old
Guatemala,GT,GTM,320,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2015,80,Total,Units,%,Estimated value,Free,,12 to 23 months old
Guatemala,GT,GTM,320,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2016,90,Total,Units,%,Estimated value,Free,,12 to 23 months old
Guatemala,GT,GTM,320,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2017,93,Total,Units,%,Estimated value,Free,,12 to 23 months old
Guatemala,GT,GTM,320,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2018,90,Total,Units,%,Estimated value,Free,,12 to 23 months old
Guatemala,GT,GTM,320,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2019,88,Total,Units,%,Estimated value,Free,,12 to 23 months old
Guatemala,GT,GTM,320,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2020,86,Total,Units,%,Estimated value,Free,,12 to 23 months old
Guatemala,GT,GTM,320,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2021,72,Total,Units,%,Estimated value,Free,,12 to 23 months old
Guatemala,GT,GTM,320,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2022,84,Total,Units,%,Estimated value,Free,,12 to 23 months old
Guinea-Bissau,GW,GNB,624,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2015,10,Total,Units,%,Estimated value,Free,,12 to 23 months old
Guinea-Bissau,GW,GNB,624,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2016,83,Total,Units,%,Estimated value,Free,,12 to 23 months old
Guinea-Bissau,GW,GNB,624,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2017,79,Total,Units,%,Estimated value,Free,,12 to 23 months old
Guinea-Bissau,GW,GNB,624,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2018,82,Total,Units,%,Estimated value,Free,,12 to 23 months old
Guinea-Bissau,GW,GNB,624,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2019,78,Total,Units,%,Estimated value,Free,,12 to 23 months old
Guinea-Bissau,GW,GNB,624,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2020,74,Total,Units,%,Estimated value,Free,,12 to 23 months old
Guinea-Bissau,GW,GNB,624,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2021,67,Total,Units,%,Estimated value,Free,,12 to 23 months old
Guinea-Bissau,GW,GNB,624,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2022,74,Total,Units,%,Estimated value,Free,,12 to 23 months old
Guyana,GY,GUY,328,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2011,50,Total,Units,%,Estimated value,Free,,12 to 23 months old
Guyana,GY,GUY,328,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2012,90,Total,Units,%,Estimated value,Free,,12 to 23 months old
Guyana,GY,GUY,328,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2013,96,Total,Units,%,Estimated value,Free,,12 to 23 months old
Guyana,GY,GUY,328,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2014,97,Total,Units,%,Estimated value,Free,,12 to 23 months old
Guyana,GY,GUY,328,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2015,94,Total,Units,%,Estimated value,Free,,12 to 23 months old
Guyana,GY,GUY,328,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2016,92,Total,Units,%,Estimated value,Free,,12 to 23 months old
Guyana,GY,GUY,328,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2017,97,Total,Units,%,Estimated value,Free,,12 to 23 months old
Guyana,GY,GUY,328,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2018,91,Total,Units,%,Estimated value,Free,,12 to 23 months old
Guyana,GY,GUY,328,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2019,98,Total,Units,%,Estimated value,Free,,12 to 23 months old
Guyana,GY,GUY,328,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2020,89,Total,Units,%,Estimated value,Free,,12 to 23 months old
Guyana,GY,GUY,328,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2021,99,Total,Units,%,Estimated value,Free,,12 to 23 months old
Guyana,GY,GUY,328,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2022,95,Total,Units,%,Estimated value,Free,,12 to 23 months old
Haiti,HT,HTI,332,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2018,12,Total,Units,%,Estimated value,Free,,12 to 23 months old
Haiti,HT,HTI,332,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2019,42,Total,Units,%,Estimated value,Free,,12 to 23 months old
Haiti,HT,HTI,332,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2020,51,Total,Units,%,Estimated value,Free,,12 to 23 months old
Haiti,HT,HTI,332,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2021,51,Total,Units,%,Estimated value,Free,,12 to 23 months old
Haiti,HT,HTI,332,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2022,51,Total,Units,%,Estimated value,Free,,12 to 23 months old
Honduras,HN,HND,340,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2011,78,Total,Units,%,Estimated value,Free,,12 to 23 months old
Honduras,HN,HND,340,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2012,97,Total,Units,%,Estimated value,Free,,12 to 23 months old
Honduras,HN,HND,340,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2013,99,Total,Units,%,Estimated value,Free,,12 to 23 months old
Honduras,HN,HND,340,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2014,99,Total,Units,%,Estimated value,Free,,12 to 23 months old
Honduras,HN,HND,340,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2015,99,Total,Units,%,Estimated value,Free,,12 to 23 months old
Honduras,HN,HND,340,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2016,94,Total,Units,%,Estimated value,Free,,12 to 23 months old
Honduras,HN,HND,340,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2017,90,Total,Units,%,Estimated value,Free,,12 to 23 months old
Honduras,HN,HND,340,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2018,91,Total,Units,%,Estimated value,Free,,12 to 23 months old
Honduras,HN,HND,340,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2019,88,Total,Units,%,Estimated value,Free,,12 to 23 months old
Honduras,HN,HND,340,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2020,80,Total,Units,%,Estimated value,Free,,12 to 23 months old
Honduras,HN,HND,340,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2021,77,Total,Units,%,Estimated value,Free,,12 to 23 months old
Honduras,HN,HND,340,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2022,78,Total,Units,%,Estimated value,Free,,12 to 23 months old
Hungary,HU,HUN,348,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2011,84,Total,Units,%,Estimated value,Free,,12 to 23 months old
Hungary,HU,HUN,348,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2012,90,Total,Units,%,Estimated value,Free,,12 to 23 months old
Hungary,HU,HUN,348,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2013,92,Total,Units,%,Estimated value,Free,,12 to 23 months old
Hungary,HU,HUN,348,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2014,93,Total,Units,%,Estimated value,Free,,12 to 23 months old
Hungary,HU,HUN,348,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2015,94,Total,Units,%,Estimated value,Free,,12 to 23 months old
Hungary,HU,HUN,348,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2016,98,Total,Units,%,Estimated value,Free,,12 to 23 months old
Hungary,HU,HUN,348,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2017,99,Total,Units,%,Estimated value,Free,,12 to 23 months old
Hungary,HU,HUN,348,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2018,99,Total,Units,%,Estimated value,Free,,12 to 23 months old
Hungary,HU,HUN,348,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2019,99,Total,Units,%,Estimated value,Free,,12 to 23 months old
Hungary,HU,HUN,348,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2020,99,Total,Units,%,Estimated value,Free,,12 to 23 months old
Hungary,HU,HUN,348,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2021,99,Total,Units,%,Estimated value,Free,,12 to 23 months old
Hungary,HU,HUN,348,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2022,99,Total,Units,%,Estimated value,Free,,12 to 23 months old
Iceland,IS,ISL,352,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2012,86,Total,Units,%,Estimated value,Free,,12 to 23 months old
Iceland,IS,ISL,352,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2013,88,Total,Units,%,Estimated value,Free,,12 to 23 months old
Iceland,IS,ISL,352,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2014,90,Total,Units,%,Estimated value,Free,,12 to 23 months old
Iceland,IS,ISL,352,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2015,91,Total,Units,%,Estimated value,Free,,12 to 23 months old
Iceland,IS,ISL,352,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2016,90,Total,Units,%,Estimated value,Free,,12 to 23 months old
Iceland,IS,ISL,352,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2017,88,Total,Units,%,Estimated value,Free,,12 to 23 months old
Iceland,IS,ISL,352,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2018,90,Total,Units,%,Estimated value,Free,,12 to 23 months old
Iceland,IS,ISL,352,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2019,92,Total,Units,%,Estimated value,Free,,12 to 23 months old
Iceland,IS,ISL,352,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2020,93,Total,Units,%,Estimated value,Free,,12 to 23 months old
Iceland,IS,ISL,352,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2021,92,Total,Units,%,Estimated value,Free,,12 to 23 months old
Iceland,IS,ISL,352,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2022,84,Total,Units,%,Estimated value,Free,,12 to 23 months old
India,IN,IND,356,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2018,6,Total,Units,%,Estimated value,Free,,12 to 23 months old
India,IN,IND,356,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2019,15,Total,Units,%,Estimated value,Free,,12 to 23 months old
India,IN,IND,356,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2020,21,Total,Units,%,Estimated value,Free,,12 to 23 months old
India,IN,IND,356,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2021,25,Total,Units,%,Estimated value,Free,,12 to 23 months old
India,IN,IND,356,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2022,66,Total,Units,%,Estimated value,Free,,12 to 23 months old
Indonesia,ID,IDN,360,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2018,0,Total,Units,%,Estimated value,Free,,12 to 23 months old
Indonesia,ID,IDN,360,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2019,3,Total,Units,%,Estimated value,Free,,12 to 23 months old
Indonesia,ID,IDN,360,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2020,4,Total,Units,%,Estimated value,Free,,12 to 23 months old
Indonesia,ID,IDN,360,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2021,1,Total,Units,%,Estimated value,Free,,12 to 23 months old
Indonesia,ID,IDN,360,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2022,6,Total,Units,%,Estimated value,Free,,12 to 23 months old
Iraq,IQ,IRQ,368,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2017,33,Total,Units,%,Estimated value,Free,,12 to 23 months old
Iraq,IQ,IRQ,368,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2018,33,Total,Units,%,Estimated value,Free,,12 to 23 months old
Iraq,IQ,IRQ,368,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2019,37,Total,Units,%,Estimated value,Free,,12 to 23 months old
Iraq,IQ,IRQ,368,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2020,0,Total,Units,%,Estimated value,Free,,12 to 23 months old
Iraq,IQ,IRQ,368,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2021,0,Total,Units,%,Estimated value,Free,,12 to 23 months old
Iraq,IQ,IRQ,368,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2022,0,Total,Units,%,Estimated value,Free,,12 to 23 months old
Ireland,IE,IRL,372,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2010,43,Total,Units,%,Estimated value,Free,,12 to 23 months old
Ireland,IE,IRL,372,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2011,90,Total,Units,%,Estimated value,Free,,12 to 23 months old
Ireland,IE,IRL,372,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2012,91,Total,Units,%,Estimated value,Free,,12 to 23 months old
Ireland,IE,IRL,372,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2013,91,Total,Units,%,Estimated value,Free,,12 to 23 months old
Ireland,IE,IRL,372,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2014,92,Total,Units,%,Estimated value,Free,,12 to 23 months old
Ireland,IE,IRL,372,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2015,92,Total,Units,%,Estimated value,Free,,12 to 23 months old
Ireland,IE,IRL,372,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2016,91,Total,Units,%,Estimated value,Free,,12 to 23 months old
Ireland,IE,IRL,372,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2017,91,Total,Units,%,Estimated value,Free,,12 to 23 months old
Ireland,IE,IRL,372,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2018,90,Total,Units,%,Estimated value,Free,,12 to 23 months old
Ireland,IE,IRL,372,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2019,86,Total,Units,%,Estimated value,Free,,12 to 23 months old
Ireland,IE,IRL,372,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2020,86,Total,Units,%,Estimated value,Free,,12 to 23 months old
Ireland,IE,IRL,372,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2021,85,Total,Units,%,Estimated value,Free,,12 to 23 months old
Ireland,IE,IRL,372,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2022,84,Total,Units,%,Estimated value,Free,,12 to 23 months old
Israel,IL,ISR,376,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2011,92,Total,Units,%,Estimated value,Free,,12 to 23 months old
Israel,IL,ISR,376,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2012,93,Total,Units,%,Estimated value,Free,,12 to 23 months old
Israel,IL,ISR,376,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2013,94,Total,Units,%,Estimated value,Free,,12 to 23 months old
Israel,IL,ISR,376,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2014,94,Total,Units,%,Estimated value,Free,,12 to 23 months old
Israel,IL,ISR,376,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2015,94,Total,Units,%,Estimated value,Free,,12 to 23 months old
Israel,IL,ISR,376,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2016,93,Total,Units,%,Estimated value,Free,,12 to 23 months old
Israel,IL,ISR,376,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2017,94,Total,Units,%,Estimated value,Free,,12 to 23 months old
Israel,IL,ISR,376,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2018,95,Total,Units,%,Estimated value,Free,,12 to 23 months old
Israel,IL,ISR,376,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2019,95,Total,Units,%,Estimated value,Free,,12 to 23 months old
Israel,IL,ISR,376,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2020,94,Total,Units,%,Estimated value,Free,,12 to 23 months old
Israel,IL,ISR,376,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2021,95,Total,Units,%,Estimated value,Free,,12 to 23 months old
Israel,IL,ISR,376,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2022,95,Total,Units,%,Estimated value,Free,,12 to 23 months old
Italy,IT,ITA,380,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2008,60,Total,Units,%,Estimated value,Free,,12 to 23 months old
Italy,IT,ITA,380,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2009,66,Total,Units,%,Estimated value,Free,,12 to 23 months old
Italy,IT,ITA,380,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2010,71,Total,Units,%,Estimated value,Free,,12 to 23 months old
Italy,IT,ITA,380,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2011,76,Total,Units,%,Estimated value,Free,,12 to 23 months old
Italy,IT,ITA,380,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2012,82,Total,Units,%,Estimated value,Free,,12 to 23 months old
Italy,IT,ITA,380,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2013,87,Total,Units,%,Estimated value,Free,,12 to 23 months old
Italy,IT,ITA,380,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2014,87,Total,Units,%,Estimated value,Free,,12 to 23 months old
Italy,IT,ITA,380,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2015,89,Total,Units,%,Estimated value,Free,,12 to 23 months old
Italy,IT,ITA,380,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2016,88,Total,Units,%,Estimated value,Free,,12 to 23 months old
Italy,IT,ITA,380,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2017,91,Total,Units,%,Estimated value,Free,,12 to 23 months old
Italy,IT,ITA,380,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2018,92,Total,Units,%,Estimated value,Free,,12 to 23 months old
Italy,IT,ITA,380,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2019,92,Total,Units,%,Estimated value,Free,,12 to 23 months old
Italy,IT,ITA,380,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2020,91,Total,Units,%,Estimated value,Free,,12 to 23 months old
Italy,IT,ITA,380,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2021,91,Total,Units,%,Estimated value,Free,,12 to 23 months old
Italy,IT,ITA,380,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2022,92,Total,Units,%,Estimated value,Free,,12 to 23 months old
Japan,JP,JPN,392,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2011,98,Total,Units,%,Estimated value,Free,,12 to 23 months old
Japan,JP,JPN,392,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2012,98,Total,Units,%,Estimated value,Free,,12 to 23 months old
Japan,JP,JPN,392,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2013,98,Total,Units,%,Estimated value,Free,,12 to 23 months old
Japan,JP,JPN,392,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2014,98,Total,Units,%,Estimated value,Free,,12 to 23 months old
Japan,JP,JPN,392,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2015,96,Total,Units,%,Estimated value,Free,,12 to 23 months old
Japan,JP,JPN,392,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2016,99,Total,Units,%,Estimated value,Free,,12 to 23 months old
Japan,JP,JPN,392,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2017,99,Total,Units,%,Estimated value,Free,,12 to 23 months old
Japan,JP,JPN,392,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2018,98,Total,Units,%,Estimated value,Free,,12 to 23 months old
Japan,JP,JPN,392,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2019,97,Total,Units,%,Estimated value,Free,,12 to 23 months old
Japan,JP,JPN,392,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2020,95,Total,Units,%,Estimated value,Free,,12 to 23 months old
Japan,JP,JPN,392,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2021,96,Total,Units,%,Estimated value,Free,,12 to 23 months old
Japan,JP,JPN,392,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2022,96,Total,Units,%,Estimated value,Free,,12 to 23 months old
Kazakhstan,KZ,KAZ,398,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2012,37,Total,Units,%,Estimated value,Free,,12 to 23 months old
Kazakhstan,KZ,KAZ,398,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2013,52,Total,Units,%,Estimated value,Free,,12 to 23 months old
Kazakhstan,KZ,KAZ,398,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2014,58,Total,Units,%,Estimated value,Free,,12 to 23 months old
Kazakhstan,KZ,KAZ,398,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2015,74,Total,Units,%,Estimated value,Free,,12 to 23 months old
Kazakhstan,KZ,KAZ,398,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2016,97,Total,Units,%,Estimated value,Free,,12 to 23 months old
Kazakhstan,KZ,KAZ,398,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2017,98,Total,Units,%,Estimated value,Free,,12 to 23 months old
Kazakhstan,KZ,KAZ,398,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2018,95,Total,Units,%,Estimated value,Free,,12 to 23 months old
Kazakhstan,KZ,KAZ,398,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2019,89,Total,Units,%,Estimated value,Free,,12 to 23 months old
Kazakhstan,KZ,KAZ,398,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2020,89,Total,Units,%,Estimated value,Free,,12 to 23 months old
Kazakhstan,KZ,KAZ,398,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2021,93,Total,Units,%,Estimated value,Free,,12 to 23 months old
Kazakhstan,KZ,KAZ,398,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2022,98,Total,Units,%,Estimated value,Free,,12 to 23 months old
Kenya,KE,KEN,404,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2011,85,Total,Units,%,Estimated value,Free,,12 to 23 months old
Kenya,KE,KEN,404,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2012,82,Total,Units,%,Estimated value,Free,,12 to 23 months old
Kenya,KE,KEN,404,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2013,75,Total,Units,%,Estimated value,Free,,12 to 23 months old
Kenya,KE,KEN,404,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2014,81,Total,Units,%,Estimated value,Free,,12 to 23 months old
Kenya,KE,KEN,404,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2015,75,Total,Units,%,Estimated value,Free,,12 to 23 months old
Kenya,KE,KEN,404,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2016,78,Total,Units,%,Estimated value,Free,,12 to 23 months old
Kenya,KE,KEN,404,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2017,82,Total,Units,%,Estimated value,Free,,12 to 23 months old
Kenya,KE,KEN,404,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2018,92,Total,Units,%,Estimated value,Free,,12 to 23 months old
Kenya,KE,KEN,404,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2019,91,Total,Units,%,Estimated value,Free,,12 to 23 months old
Kenya,KE,KEN,404,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2020,90,Total,Units,%,Estimated value,Free,,12 to 23 months old
Kenya,KE,KEN,404,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2021,92,Total,Units,%,Estimated value,Free,,12 to 23 months old
Kenya,KE,KEN,404,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2022,91,Total,Units,%,Estimated value,Free,,12 to 23 months old
Kiribati,KI,KIR,296,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2013,40,Total,Units,%,Estimated value,Free,,12 to 23 months old
Kiribati,KI,KIR,296,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2014,57,Total,Units,%,Estimated value,Free,,12 to 23 months old
Kiribati,KI,KIR,296,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2015,74,Total,Units,%,Estimated value,Free,,12 to 23 months old
Kiribati,KI,KIR,296,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2016,79,Total,Units,%,Estimated value,Free,,12 to 23 months old
Kiribati,KI,KIR,296,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2017,91,Total,Units,%,Estimated value,Free,,12 to 23 months old
Kiribati,KI,KIR,296,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2018,94,Total,Units,%,Estimated value,Free,,12 to 23 months old
Kiribati,KI,KIR,296,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2019,97,Total,Units,%,Estimated value,Free,,12 to 23 months old
Kiribati,KI,KIR,296,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2020,91,Total,Units,%,Estimated value,Free,,12 to 23 months old
Kiribati,KI,KIR,296,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2021,90,Total,Units,%,Estimated value,Free,,12 to 23 months old
Kiribati,KI,KIR,296,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2022,91,Total,Units,%,Estimated value,Free,,12 to 23 months old
Kuwait,KW,KWT,414,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2008,99,Total,Units,%,Estimated value,Free,,12 to 23 months old
Kuwait,KW,KWT,414,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2009,99,Total,Units,%,Estimated value,Free,,12 to 23 months old
Kuwait,KW,KWT,414,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2010,98,Total,Units,%,Estimated value,Free,,12 to 23 months old
Kuwait,KW,KWT,414,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2011,99,Total,Units,%,Estimated value,Free,,12 to 23 months old
Kuwait,KW,KWT,414,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2012,99,Total,Units,%,Estimated value,Free,,12 to 23 months old
Kuwait,KW,KWT,414,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2013,99,Total,Units,%,Estimated value,Free,,12 to 23 months old
Kuwait,KW,KWT,414,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2014,94,Total,Units,%,Estimated value,Free,,12 to 23 months old
Kuwait,KW,KWT,414,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2015,99,Total,Units,%,Estimated value,Free,,12 to 23 months old
Kuwait,KW,KWT,414,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2016,99,Total,Units,%,Estimated value,Free,,12 to 23 months old
Kuwait,KW,KWT,414,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2017,99,Total,Units,%,Estimated value,Free,,12 to 23 months old
Kuwait,KW,KWT,414,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2018,91,Total,Units,%,Estimated value,Free,,12 to 23 months old
Kuwait,KW,KWT,414,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2019,93,Total,Units,%,Estimated value,Free,,12 to 23 months old
Kuwait,KW,KWT,414,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2020,94,Total,Units,%,Estimated value,Free,,12 to 23 months old
Kuwait,KW,KWT,414,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2021,96,Total,Units,%,Estimated value,Free,,12 to 23 months old
Kuwait,KW,KWT,414,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2022,99,Total,Units,%,Estimated value,Free,,12 to 23 months old
Kyrgyzstan,KG,KGZ,417,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2017,88,Total,Units,%,Estimated value,Free,,12 to 23 months old
Kyrgyzstan,KG,KGZ,417,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2018,92,Total,Units,%,Estimated value,Free,,12 to 23 months old
Kyrgyzstan,KG,KGZ,417,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2019,96,Total,Units,%,Estimated value,Free,,12 to 23 months old
Kyrgyzstan,KG,KGZ,417,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2020,90,Total,Units,%,Estimated value,Free,,12 to 23 months old
Kyrgyzstan,KG,KGZ,417,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2021,90,Total,Units,%,Estimated value,Free,,12 to 23 months old
Kyrgyzstan,KG,KGZ,417,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2022,92,Total,Units,%,Estimated value,Free,,12 to 23 months old
Lao People's Democratic Republic,LA,LAO,418,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2014,60,Total,Units,%,Estimated value,Free,,12 to 23 months old
Lao People's Democratic Republic,LA,LAO,418,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2015,74,Total,Units,%,Estimated value,Free,,12 to 23 months old
Lao People's Democratic Republic,LA,LAO,418,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2016,78,Total,Units,%,Estimated value,Free,,12 to 23 months old
Lao People's Democratic Republic,LA,LAO,418,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2017,82,Total,Units,%,Estimated value,Free,,12 to 23 months old
Lao People's Democratic Republic,LA,LAO,418,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2018,84,Total,Units,%,Estimated value,Free,,12 to 23 months old
Lao People's Democratic Republic,LA,LAO,418,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2019,81,Total,Units,%,Estimated value,Free,,12 to 23 months old
Lao People's Democratic Republic,LA,LAO,418,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2020,77,Total,Units,%,Estimated value,Free,,12 to 23 months old
Lao People's Democratic Republic,LA,LAO,418,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2021,74,Total,Units,%,Estimated value,Free,,12 to 23 months old
Lao People's Democratic Republic,LA,LAO,418,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2022,78,Total,Units,%,Estimated value,Free,,12 to 23 months old
Latvia,LV,LVA,428,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2011,76,Total,Units,%,Estimated value,Free,,12 to 23 months old
Latvia,LV,LVA,428,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2012,55,Total,Units,%,Estimated value,Free,,12 to 23 months old
Latvia,LV,LVA,428,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2013,87,Total,Units,%,Estimated value,Free,,12 to 23 months old
Latvia,LV,LVA,428,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2014,84,Total,Units,%,Estimated value,Free,,12 to 23 months old
Latvia,LV,LVA,428,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2015,85,Total,Units,%,Estimated value,Free,,12 to 23 months old
Latvia,LV,LVA,428,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2016,84,Total,Units,%,Estimated value,Free,,12 to 23 months old
Latvia,LV,LVA,428,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2017,87,Total,Units,%,Estimated value,Free,,12 to 23 months old
Latvia,LV,LVA,428,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2018,84,Total,Units,%,Estimated value,Free,,12 to 23 months old
Latvia,LV,LVA,428,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2019,84,Total,Units,%,Estimated value,Free,,12 to 23 months old
Latvia,LV,LVA,428,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2020,91,Total,Units,%,Estimated value,Free,,12 to 23 months old
Latvia,LV,LVA,428,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2021,92,Total,Units,%,Estimated value,Free,,12 to 23 months old
Latvia,LV,LVA,428,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2022,87,Total,Units,%,Estimated value,Free,,12 to 23 months old
Lebanon,LB,LBN,422,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2017,82,Total,Units,%,Estimated value,Free,,12 to 23 months old
Lebanon,LB,LBN,422,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2018,82,Total,Units,%,Estimated value,Free,,12 to 23 months old
Lebanon,LB,LBN,422,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2019,82,Total,Units,%,Estimated value,Free,,12 to 23 months old
Lebanon,LB,LBN,422,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2020,74,Total,Units,%,Estimated value,Free,,12 to 23 months old
Lebanon,LB,LBN,422,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2021,70,Total,Units,%,Estimated value,Free,,12 to 23 months old
Lebanon,LB,LBN,422,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2022,70,Total,Units,%,Estimated value,Free,,12 to 23 months old
Lesotho,LS,LSO,426,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2015,29,Total,Units,%,Estimated value,Free,,12 to 23 months old
Lesotho,LS,LSO,426,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2016,87,Total,Units,%,Estimated value,Free,,12 to 23 months old
Lesotho,LS,LSO,426,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2017,87,Total,Units,%,Estimated value,Free,,12 to 23 months old
Lesotho,LS,LSO,426,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2018,87,Total,Units,%,Estimated value,Free,,12 to 23 months old
Lesotho,LS,LSO,426,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2019,87,Total,Units,%,Estimated value,Free,,12 to 23 months old
Lesotho,LS,LSO,426,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2020,87,Total,Units,%,Estimated value,Free,,12 to 23 months old
Lesotho,LS,LSO,426,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2021,87,Total,Units,%,Estimated value,Free,,12 to 23 months old
Lesotho,LS,LSO,426,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2022,87,Total,Units,%,Estimated value,Free,,12 to 23 months old
Liberia,LR,LBR,430,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2014,25,Total,Units,%,Estimated value,Free,,12 to 23 months old
Liberia,LR,LBR,430,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2015,36,Total,Units,%,Estimated value,Free,,12 to 23 months old
Liberia,LR,LBR,430,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2016,73,Total,Units,%,Estimated value,Free,,12 to 23 months old
Liberia,LR,LBR,430,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2017,78,Total,Units,%,Estimated value,Free,,12 to 23 months old
Liberia,LR,LBR,430,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2018,78,Total,Units,%,Estimated value,Free,,12 to 23 months old
Liberia,LR,LBR,430,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2019,68,Total,Units,%,Estimated value,Free,,12 to 23 months old
Liberia,LR,LBR,430,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2020,65,Total,Units,%,Estimated value,Free,,12 to 23 months old
Liberia,LR,LBR,430,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2021,65,Total,Units,%,Estimated value,Free,,12 to 23 months old
Liberia,LR,LBR,430,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2022,74,Total,Units,%,Estimated value,Free,,12 to 23 months old
Libyan Arab Jamahiriya,LY,LBY,434,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2014,39,Total,Units,%,Estimated value,Free,,12 to 23 months old
Libya,LY,LBY,434,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2014,39,Total,Units,%,Estimated value,Free,,12 to 23 months old
Libyan Arab Jamahiriya,LY,LBY,434,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2015,71,Total,Units,%,Estimated value,Free,,12 to 23 months old
Libya,LY,LBY,434,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2015,71,Total,Units,%,Estimated value,Free,,12 to 23 months old
Libyan Arab Jamahiriya,LY,LBY,434,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2016,96,Total,Units,%,Estimated value,Free,,12 to 23 months old
Libya,LY,LBY,434,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2016,96,Total,Units,%,Estimated value,Free,,12 to 23 months old
Libyan Arab Jamahiriya,LY,LBY,434,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2017,94,Total,Units,%,Estimated value,Free,,12 to 23 months old
Libya,LY,LBY,434,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2017,94,Total,Units,%,Estimated value,Free,,12 to 23 months old
Libyan Arab Jamahiriya,LY,LBY,434,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2018,72,Total,Units,%,Estimated value,Free,,12 to 23 months old
Libya,LY,LBY,434,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2018,72,Total,Units,%,Estimated value,Free,,12 to 23 months old
Libyan Arab Jamahiriya,LY,LBY,434,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2019,73,Total,Units,%,Estimated value,Free,,12 to 23 months old
Libya,LY,LBY,434,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2019,73,Total,Units,%,Estimated value,Free,,12 to 23 months old
Libyan Arab Jamahiriya,LY,LBY,434,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2020,73,Total,Units,%,Estimated value,Free,,12 to 23 months old
Libya,LY,LBY,434,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2020,73,Total,Units,%,Estimated value,Free,,12 to 23 months old
Libyan Arab Jamahiriya,LY,LBY,434,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2021,73,Total,Units,%,Estimated value,Free,,12 to 23 months old
Libya,LY,LBY,434,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2021,73,Total,Units,%,Estimated value,Free,,12 to 23 months old
Libyan Arab Jamahiriya,LY,LBY,434,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2022,73,Total,Units,%,Estimated value,Free,,12 to 23 months old
Libya,LY,LBY,434,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2022,73,Total,Units,%,Estimated value,Free,,12 to 23 months old
Lithuania,LT,LTU,440,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2016,82,Total,Units,%,Estimated value,Free,,12 to 23 months old
Lithuania,LT,LTU,440,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2017,82,Total,Units,%,Estimated value,Free,,12 to 23 months old
Lithuania,LT,LTU,440,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2018,82,Total,Units,%,Estimated value,Free,,12 to 23 months old
Lithuania,LT,LTU,440,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2019,82,Total,Units,%,Estimated value,Free,,12 to 23 months old
Lithuania,LT,LTU,440,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2020,83,Total,Units,%,Estimated value,Free,,12 to 23 months old
Lithuania,LT,LTU,440,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2021,82,Total,Units,%,Estimated value,Free,,12 to 23 months old
Lithuania,LT,LTU,440,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2022,81,Total,Units,%,Estimated value,Free,,12 to 23 months old
Luxembourg,LU,LUX,442,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2008,86,Total,Units,%,Estimated value,Free,,12 to 23 months old
Luxembourg,LU,LUX,442,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2009,86,Total,Units,%,Estimated value,Free,,12 to 23 months old
Luxembourg,LU,LUX,442,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2010,86,Total,Units,%,Estimated value,Free,,12 to 23 months old
Luxembourg,LU,LUX,442,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2011,86,Total,Units,%,Estimated value,Free,,12 to 23 months old
Luxembourg,LU,LUX,442,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2012,95,Total,Units,%,Estimated value,Free,,12 to 23 months old
Luxembourg,LU,LUX,442,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2013,95,Total,Units,%,Estimated value,Free,,12 to 23 months old
Luxembourg,LU,LUX,442,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2014,95,Total,Units,%,Estimated value,Free,,12 to 23 months old
Luxembourg,LU,LUX,442,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2015,95,Total,Units,%,Estimated value,Free,,12 to 23 months old
Luxembourg,LU,LUX,442,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2016,95,Total,Units,%,Estimated value,Free,,12 to 23 months old
Luxembourg,LU,LUX,442,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2017,95,Total,Units,%,Estimated value,Free,,12 to 23 months old
Luxembourg,LU,LUX,442,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2018,96,Total,Units,%,Estimated value,Free,,12 to 23 months old
Luxembourg,LU,LUX,442,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2019,96,Total,Units,%,Estimated value,Free,,12 to 23 months old
Luxembourg,LU,LUX,442,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2020,96,Total,Units,%,Estimated value,Free,,12 to 23 months old
Luxembourg,LU,LUX,442,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2021,96,Total,Units,%,Estimated value,Free,,12 to 23 months old
Luxembourg,LU,LUX,442,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2022,96,Total,Units,%,Estimated value,Free,,12 to 23 months old
Madagascar,MG,MDG,450,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2013,76,Total,Units,%,Estimated value,Free,,12 to 23 months old
Madagascar,MG,MDG,450,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2014,68,Total,Units,%,Estimated value,Free,,12 to 23 months old
Madagascar,MG,MDG,450,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2015,62,Total,Units,%,Estimated value,Free,,12 to 23 months old
Madagascar,MG,MDG,450,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2016,65,Total,Units,%,Estimated value,Free,,12 to 23 months old
Madagascar,MG,MDG,450,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2017,62,Total,Units,%,Estimated value,Free,,12 to 23 months old
Madagascar,MG,MDG,450,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2018,73,Total,Units,%,Estimated value,Free,,12 to 23 months old
Madagascar,MG,MDG,450,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2019,69,Total,Units,%,Estimated value,Free,,12 to 23 months old
Madagascar,MG,MDG,450,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2020,67,Total,Units,%,Estimated value,Free,,12 to 23 months old
Madagascar,MG,MDG,450,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2021,57,Total,Units,%,Estimated value,Free,,12 to 23 months old
Madagascar,MG,MDG,450,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2022,57,Total,Units,%,Estimated value,Free,,12 to 23 months old
Malawi,MW,MWI,454,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2012,99,Total,Units,%,Estimated value,Free,,12 to 23 months old
Malawi,MW,MWI,454,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2013,89,Total,Units,%,Estimated value,Free,,12 to 23 months old
Malawi,MW,MWI,454,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2014,87,Total,Units,%,Estimated value,Free,,12 to 23 months old
Malawi,MW,MWI,454,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2015,88,Total,Units,%,Estimated value,Free,,12 to 23 months old
Malawi,MW,MWI,454,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2016,83,Total,Units,%,Estimated value,Free,,12 to 23 months old
Malawi,MW,MWI,454,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2017,88,Total,Units,%,Estimated value,Free,,12 to 23 months old
Malawi,MW,MWI,454,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2018,92,Total,Units,%,Estimated value,Free,,12 to 23 months old
Malawi,MW,MWI,454,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2019,95,Total,Units,%,Estimated value,Free,,12 to 23 months old
Malawi,MW,MWI,454,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2020,93,Total,Units,%,Estimated value,Free,,12 to 23 months old
Malawi,MW,MWI,454,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2021,93,Total,Units,%,Estimated value,Free,,12 to 23 months old
Malawi,MW,MWI,454,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2022,87,Total,Units,%,Estimated value,Free,,12 to 23 months old
Malaysia,MY,MYS,458,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2021,57,Total,Units,%,Estimated value,Free,,12 to 23 months old
Malaysia,MY,MYS,458,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2022,57,Total,Units,%,Estimated value,Free,,12 to 23 months old
Mali,ML,MLI,466,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2011,56,Total,Units,%,Estimated value,Free,,12 to 23 months old
Mali,ML,MLI,466,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2012,58,Total,Units,%,Estimated value,Free,,12 to 23 months old
Mali,ML,MLI,466,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2013,59,Total,Units,%,Estimated value,Free,,12 to 23 months old
Mali,ML,MLI,466,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2014,57,Total,Units,%,Estimated value,Free,,12 to 23 months old
Mali,ML,MLI,466,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2015,67,Total,Units,%,Estimated value,Free,,12 to 23 months old
Mali,ML,MLI,466,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2016,76,Total,Units,%,Estimated value,Free,,12 to 23 months old
Mali,ML,MLI,466,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2017,74,Total,Units,%,Estimated value,Free,,12 to 23 months old
Mali,ML,MLI,466,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2018,74,Total,Units,%,Estimated value,Free,,12 to 23 months old
Mali,ML,MLI,466,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2019,74,Total,Units,%,Estimated value,Free,,12 to 23 months old
Mali,ML,MLI,466,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2020,66,Total,Units,%,Estimated value,Free,,12 to 23 months old
Mali,ML,MLI,466,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2021,77,Total,Units,%,Estimated value,Free,,12 to 23 months old
Mali,ML,MLI,466,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2022,77,Total,Units,%,Estimated value,Free,,12 to 23 months old
Malta,MT,MLT,470,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2021,99,Total,Units,%,Estimated value,Free,,12 to 23 months old
Malta,MT,MLT,470,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2022,99,Total,Units,%,Estimated value,Free,,12 to 23 months old
Marshall Islands,MH,MHL,584,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2009,49,Total,Units,%,Estimated value,Free,,12 to 23 months old
Marshall Islands,MH,MHL,584,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2010,24,Total,Units,%,Estimated value,Free,,12 to 23 months old
Marshall Islands,MH,MHL,584,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2011,35,Total,Units,%,Estimated value,Free,,12 to 23 months old
Marshall Islands,MH,MHL,584,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2012,46,Total,Units,%,Estimated value,Free,,12 to 23 months old
Marshall Islands,MH,MHL,584,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2013,38,Total,Units,%,Estimated value,Free,,12 to 23 months old
Marshall Islands,MH,MHL,584,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2014,29,Total,Units,%,Estimated value,Free,,12 to 23 months old
Marshall Islands,MH,MHL,584,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2015,75,Total,Units,%,Estimated value,Free,,12 to 23 months old
Marshall Islands,MH,MHL,584,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2016,65,Total,Units,%,Estimated value,Free,,12 to 23 months old
Marshall Islands,MH,MHL,584,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2017,72,Total,Units,%,Estimated value,Free,,12 to 23 months old
Marshall Islands,MH,MHL,584,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2018,67,Total,Units,%,Estimated value,Free,,12 to 23 months old
Marshall Islands,MH,MHL,584,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2019,63,Total,Units,%,Estimated value,Free,,12 to 23 months old
Marshall Islands,MH,MHL,584,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2020,38,Total,Units,%,Estimated value,Free,,12 to 23 months old
Marshall Islands,MH,MHL,584,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2021,61,Total,Units,%,Estimated value,Free,,12 to 23 months old
Marshall Islands,MH,MHL,584,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2022,29,Total,Units,%,Estimated value,Free,,12 to 23 months old
Mauritania,MR,MRT,478,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2013,1,Total,Units,%,Estimated value,Free,,12 to 23 months old
Mauritania,MR,MRT,478,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2014,71,Total,Units,%,Estimated value,Free,,12 to 23 months old
Mauritania,MR,MRT,478,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2015,71,Total,Units,%,Estimated value,Free,,12 to 23 months old
Mauritania,MR,MRT,478,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2016,71,Total,Units,%,Estimated value,Free,,12 to 23 months old
Mauritania,MR,MRT,478,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2017,72,Total,Units,%,Estimated value,Free,,12 to 23 months old
Mauritania,MR,MRT,478,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2018,72,Total,Units,%,Estimated value,Free,,12 to 23 months old
Mauritania,MR,MRT,478,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2019,76,Total,Units,%,Estimated value,Free,,12 to 23 months old
Mauritania,MR,MRT,478,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2020,70,Total,Units,%,Estimated value,Free,,12 to 23 months old
Mauritania,MR,MRT,478,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2021,65,Total,Units,%,Estimated value,Free,,12 to 23 months old
Mauritania,MR,MRT,478,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2022,73,Total,Units,%,Estimated value,Free,,12 to 23 months old
Mauritius,MU,MUS,480,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2016,10,Total,Units,%,Estimated value,Free,,12 to 23 months old
Mauritius,MU,MUS,480,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2017,84,Total,Units,%,Estimated value,Free,,12 to 23 months old
Mauritius,MU,MUS,480,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2018,96,Total,Units,%,Estimated value,Free,,12 to 23 months old
Mauritius,MU,MUS,480,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2019,97,Total,Units,%,Estimated value,Free,,12 to 23 months old
Mauritius,MU,MUS,480,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2020,86,Total,Units,%,Estimated value,Free,,12 to 23 months old
Mauritius,MU,MUS,480,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2021,94,Total,Units,%,Estimated value,Free,,12 to 23 months old
Mauritius,MU,MUS,480,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2022,97,Total,Units,%,Estimated value,Free,,12 to 23 months old
Mexico,MX,MEX,484,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2008,14,Total,Units,%,Estimated value,Free,,12 to 23 months old
Mexico,MX,MEX,484,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2009,46,Total,Units,%,Estimated value,Free,,12 to 23 months old
Mexico,MX,MEX,484,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2010,92,Total,Units,%,Estimated value,Free,,12 to 23 months old
Mexico,MX,MEX,484,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2011,98,Total,Units,%,Estimated value,Free,,12 to 23 months old
Mexico,MX,MEX,484,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2012,99,Total,Units,%,Estimated value,Free,,12 to 23 months old
Mexico,MX,MEX,484,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2013,84,Total,Units,%,Estimated value,Free,,12 to 23 months old
Mexico,MX,MEX,484,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2014,94,Total,Units,%,Estimated value,Free,,12 to 23 months old
Mexico,MX,MEX,484,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2015,93,Total,Units,%,Estimated value,Free,,12 to 23 months old
Mexico,MX,MEX,484,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2016,92,Total,Units,%,Estimated value,Free,,12 to 23 months old
Mexico,MX,MEX,484,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2017,92,Total,Units,%,Estimated value,Free,,12 to 23 months old
Mexico,MX,MEX,484,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2018,88,Total,Units,%,Estimated value,Free,,12 to 23 months old
Mexico,MX,MEX,484,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2019,86,Total,Units,%,Estimated value,Free,,12 to 23 months old
Mexico,MX,MEX,484,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2020,77,Total,Units,%,Estimated value,Free,,12 to 23 months old
Mexico,MX,MEX,484,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2021,83,Total,Units,%,Estimated value,Free,,12 to 23 months old
Mexico,MX,MEX,484,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2022,84,Total,Units,%,Estimated value,Free,,12 to 23 months old
"Micronesia, Federated States of",FM,FSM,583,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2010,70,Total,Units,%,Estimated value,Free,,12 to 23 months old
"Micronesia, Federated States of",FM,FSM,583,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2011,63,Total,Units,%,Estimated value,Free,,12 to 23 months old
"Micronesia, Federated States of",FM,FSM,583,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2012,60,Total,Units,%,Estimated value,Free,,12 to 23 months old
"Micronesia, Federated States of",FM,FSM,583,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2013,61,Total,Units,%,Estimated value,Free,,12 to 23 months old
"Micronesia, Federated States of",FM,FSM,583,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2014,64,Total,Units,%,Estimated value,Free,,12 to 23 months old
"Micronesia, Federated States of",FM,FSM,583,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2015,67,Total,Units,%,Estimated value,Free,,12 to 23 months old
"Micronesia, Federated States of",FM,FSM,583,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2016,63,Total,Units,%,Estimated value,Free,,12 to 23 months old
"Micronesia, Federated States of",FM,FSM,583,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2017,65,Total,Units,%,Estimated value,Free,,12 to 23 months old
"Micronesia, Federated States of",FM,FSM,583,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2018,67,Total,Units,%,Estimated value,Free,,12 to 23 months old
"Micronesia, Federated States of",FM,FSM,583,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2019,73,Total,Units,%,Estimated value,Free,,12 to 23 months old
"Micronesia, Federated States of",FM,FSM,583,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2020,79,Total,Units,%,Estimated value,Free,,12 to 23 months old
"Micronesia, Federated States of",FM,FSM,583,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2021,70,Total,Units,%,Estimated value,Free,,12 to 23 months old
"Micronesia, Federated States of",FM,FSM,583,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2022,65,Total,Units,%,Estimated value,Free,,12 to 23 months old
Mongolia,MN,MNG,496,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2017,13,Total,Units,%,Estimated value,Free,,12 to 23 months old
Mongolia,MN,MNG,496,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2018,26,Total,Units,%,Estimated value,Free,,12 to 23 months old
Mongolia,MN,MNG,496,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2019,49,Total,Units,%,Estimated value,Free,,12 to 23 months old
Mongolia,MN,MNG,496,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2020,92,Total,Units,%,Estimated value,Free,,12 to 23 months old
Mongolia,MN,MNG,496,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2021,95,Total,Units,%,Estimated value,Free,,12 to 23 months old
Mongolia,MN,MNG,496,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2022,94,Total,Units,%,Estimated value,Free,,12 to 23 months old
Morocco,MA,MAR,504,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2010,1,Total,Units,%,Estimated value,Free,,12 to 23 months old
Morocco,MA,MAR,504,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2011,23,Total,Units,%,Estimated value,Free,,12 to 23 months old
Morocco,MA,MAR,504,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2012,72,Total,Units,%,Estimated value,Free,,12 to 23 months old
Morocco,MA,MAR,504,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2013,80,Total,Units,%,Estimated value,Free,,12 to 23 months old
Morocco,MA,MAR,504,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2014,90,Total,Units,%,Estimated value,Free,,12 to 23 months old
Morocco,MA,MAR,504,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2015,95,Total,Units,%,Estimated value,Free,,12 to 23 months old
Morocco,MA,MAR,504,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2016,98,Total,Units,%,Estimated value,Free,,12 to 23 months old
Morocco,MA,MAR,504,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2017,99,Total,Units,%,Estimated value,Free,,12 to 23 months old
Morocco,MA,MAR,504,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2018,99,Total,Units,%,Estimated value,Free,,12 to 23 months old
Morocco,MA,MAR,504,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2019,98,Total,Units,%,Estimated value,Free,,12 to 23 months old
Morocco,MA,MAR,504,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2020,98,Total,Units,%,Estimated value,Free,,12 to 23 months old
Morocco,MA,MAR,504,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2021,98,Total,Units,%,Estimated value,Free,,12 to 23 months old
Morocco,MA,MAR,504,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2022,98,Total,Units,%,Estimated value,Free,,12 to 23 months old
Mozambique,MZ,MOZ,508,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2013,45,Total,Units,%,Estimated value,Free,,12 to 23 months old
Mozambique,MZ,MOZ,508,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2014,73,Total,Units,%,Estimated value,Free,,12 to 23 months old
Mozambique,MZ,MOZ,508,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2015,80,Total,Units,%,Estimated value,Free,,12 to 23 months old
Mozambique,MZ,MOZ,508,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2016,80,Total,Units,%,Estimated value,Free,,12 to 23 months old
Mozambique,MZ,MOZ,508,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2017,80,Total,Units,%,Estimated value,Free,,12 to 23 months old
Mozambique,MZ,MOZ,508,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2018,80,Total,Units,%,Estimated value,Free,,12 to 23 months old
Mozambique,MZ,MOZ,508,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2019,80,Total,Units,%,Estimated value,Free,,12 to 23 months old
Mozambique,MZ,MOZ,508,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2020,65,Total,Units,%,Estimated value,Free,,12 to 23 months old
Mozambique,MZ,MOZ,508,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2021,70,Total,Units,%,Estimated value,Free,,12 to 23 months old
Mozambique,MZ,MOZ,508,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2022,70,Total,Units,%,Estimated value,Free,,12 to 23 months old
Myanmar,MM,MMR,104,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2016,14,Total,Units,%,Estimated value,Free,,12 to 23 months old
Burma,MM,MMR,104,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2016,14,Total,Units,%,Estimated value,Free,,12 to 23 months old
Myanmar,MM,MMR,104,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2017,89,Total,Units,%,Estimated value,Free,,12 to 23 months old
Burma,MM,MMR,104,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2017,89,Total,Units,%,Estimated value,Free,,12 to 23 months old
Myanmar,MM,MMR,104,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2018,91,Total,Units,%,Estimated value,Free,,12 to 23 months old
Burma,MM,MMR,104,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2018,91,Total,Units,%,Estimated value,Free,,12 to 23 months old
Myanmar,MM,MMR,104,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2019,90,Total,Units,%,Estimated value,Free,,12 to 23 months old
Burma,MM,MMR,104,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2019,90,Total,Units,%,Estimated value,Free,,12 to 23 months old
Myanmar,MM,MMR,104,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2020,86,Total,Units,%,Estimated value,Free,,12 to 23 months old
Burma,MM,MMR,104,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2020,86,Total,Units,%,Estimated value,Free,,12 to 23 months old
Myanmar,MM,MMR,104,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2021,40,Total,Units,%,Estimated value,Free,,12 to 23 months old
Burma,MM,MMR,104,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2021,40,Total,Units,%,Estimated value,Free,,12 to 23 months old
Myanmar,MM,MMR,104,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2022,57,Total,Units,%,Estimated value,Free,,12 to 23 months old
Burma,MM,MMR,104,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2022,57,Total,Units,%,Estimated value,Free,,12 to 23 months old
Namibia,,NAM,516,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2015,81,Total,Units,%,Estimated value,Free,,12 to 23 months old
Namibia,,NAM,516,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2016,84,Total,Units,%,Estimated value,Free,,12 to 23 months old
Namibia,,NAM,516,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2017,67,Total,Units,%,Estimated value,Free,,12 to 23 months old
Namibia,,NAM,516,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2018,61,Total,Units,%,Estimated value,Free,,12 to 23 months old
Namibia,,NAM,516,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2019,57,Total,Units,%,Estimated value,Free,,12 to 23 months old
Namibia,,NAM,516,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2020,78,Total,Units,%,Estimated value,Free,,12 to 23 months old
Namibia,,NAM,516,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2021,79,Total,Units,%,Estimated value,Free,,12 to 23 months old
Namibia,,NAM,516,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2022,85,Total,Units,%,Estimated value,Free,,12 to 23 months old
Nauru,NR,NRU,520,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2021,59,Total,Units,%,Estimated value,Free,,12 to 23 months old
Nauru,NR,NRU,520,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2022,59,Total,Units,%,Estimated value,Free,,12 to 23 months old
Nepal,NP,NPL,524,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2015,5,Total,Units,%,Estimated value,Free,,12 to 23 months old
Nepal,NP,NPL,524,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2016,46,Total,Units,%,Estimated value,Free,,12 to 23 months old
Nepal,NP,NPL,524,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2017,80,Total,Units,%,Estimated value,Free,,12 to 23 months old
Nepal,NP,NPL,524,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2018,82,Total,Units,%,Estimated value,Free,,12 to 23 months old
Nepal,NP,NPL,524,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2019,83,Total,Units,%,Estimated value,Free,,12 to 23 months old
Nepal,NP,NPL,524,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2020,80,Total,Units,%,Estimated value,Free,,12 to 23 months old
Nepal,NP,NPL,524,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2021,84,Total,Units,%,Estimated value,Free,,12 to 23 months old
Nepal,NP,NPL,524,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2022,83,Total,Units,%,Estimated value,Free,,12 to 23 months old
Netherlands,NL,NLD,528,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2009,96,Total,Units,%,Estimated value,Free,,12 to 23 months old
Netherlands,NL,NLD,528,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2010,96,Total,Units,%,Estimated value,Free,,12 to 23 months old
Netherlands,NL,NLD,528,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2011,96,Total,Units,%,Estimated value,Free,,12 to 23 months old
Netherlands,NL,NLD,528,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2012,96,Total,Units,%,Estimated value,Free,,12 to 23 months old
Netherlands,NL,NLD,528,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2013,96,Total,Units,%,Estimated value,Free,,12 to 23 months old
Netherlands,NL,NLD,528,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2014,95,Total,Units,%,Estimated value,Free,,12 to 23 months old
Netherlands,NL,NLD,528,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2015,94,Total,Units,%,Estimated value,Free,,12 to 23 months old
Netherlands,NL,NLD,528,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2016,94,Total,Units,%,Estimated value,Free,,12 to 23 months old
Netherlands,NL,NLD,528,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2017,93,Total,Units,%,Estimated value,Free,,12 to 23 months old
Netherlands,NL,NLD,528,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2018,93,Total,Units,%,Estimated value,Free,,12 to 23 months old
Netherlands,NL,NLD,528,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2019,93,Total,Units,%,Estimated value,Free,,12 to 23 months old
Netherlands,NL,NLD,528,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2020,93,Total,Units,%,Estimated value,Free,,12 to 23 months old
Netherlands,NL,NLD,528,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2021,93,Total,Units,%,Estimated value,Free,,12 to 23 months old
Netherlands,NL,NLD,528,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2022,90,Total,Units,%,Estimated value,Free,,12 to 23 months old
New Zealand,NZ,NZL,554,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2009,87,Total,Units,%,Estimated value,Free,,12 to 23 months old
New Zealand,NZ,NZL,554,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2010,89,Total,Units,%,Estimated value,Free,,12 to 23 months old
New Zealand,NZ,NZL,554,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2011,92,Total,Units,%,Estimated value,Free,,12 to 23 months old
New Zealand,NZ,NZL,554,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2012,92,Total,Units,%,Estimated value,Free,,12 to 23 months old
New Zealand,NZ,NZL,554,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2013,93,Total,Units,%,Estimated value,Free,,12 to 23 months old
New Zealand,NZ,NZL,554,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2014,93,Total,Units,%,Estimated value,Free,,12 to 23 months old
New Zealand,NZ,NZL,554,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2015,93,Total,Units,%,Estimated value,Free,,12 to 23 months old
New Zealand,NZ,NZL,554,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2016,93,Total,Units,%,Estimated value,Free,,12 to 23 months old
New Zealand,NZ,NZL,554,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2017,94,Total,Units,%,Estimated value,Free,,12 to 23 months old
New Zealand,NZ,NZL,554,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2018,96,Total,Units,%,Estimated value,Free,,12 to 23 months old
New Zealand,NZ,NZL,554,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2019,91,Total,Units,%,Estimated value,Free,,12 to 23 months old
New Zealand,NZ,NZL,554,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2020,92,Total,Units,%,Estimated value,Free,,12 to 23 months old
New Zealand,NZ,NZL,554,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2021,95,Total,Units,%,Estimated value,Free,,12 to 23 months old
New Zealand,NZ,NZL,554,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2022,86,Total,Units,%,Estimated value,Free,,12 to 23 months old
Nicaragua,NI,NIC,558,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2011,61,Total,Units,%,Estimated value,Free,,12 to 23 months old
Nicaragua,NI,NIC,558,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2012,98,Total,Units,%,Estimated value,Free,,12 to 23 months old
Nicaragua,NI,NIC,558,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2013,98,Total,Units,%,Estimated value,Free,,12 to 23 months old
Nicaragua,NI,NIC,558,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2014,98,Total,Units,%,Estimated value,Free,,12 to 23 months old
Nicaragua,NI,NIC,558,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2015,98,Total,Units,%,Estimated value,Free,,12 to 23 months old
Nicaragua,NI,NIC,558,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2016,98,Total,Units,%,Estimated value,Free,,12 to 23 months old
Nicaragua,NI,NIC,558,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2017,98,Total,Units,%,Estimated value,Free,,12 to 23 months old
Nicaragua,NI,NIC,558,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2018,98,Total,Units,%,Estimated value,Free,,12 to 23 months old
Nicaragua,NI,NIC,558,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2019,98,Total,Units,%,Estimated value,Free,,12 to 23 months old
Nicaragua,NI,NIC,558,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2020,92,Total,Units,%,Estimated value,Free,,12 to 23 months old
Nicaragua,NI,NIC,558,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2021,87,Total,Units,%,Estimated value,Free,,12 to 23 months old
Nicaragua,NI,NIC,558,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2022,92,Total,Units,%,Estimated value,Free,,12 to 23 months old
Niger,NE,NER,562,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2014,13,Total,Units,%,Estimated value,Free,,12 to 23 months old
Niger,NE,NER,562,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2015,49,Total,Units,%,Estimated value,Free,,12 to 23 months old
Niger,NE,NER,562,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2016,76,Total,Units,%,Estimated value,Free,,12 to 23 months old
Niger,NE,NER,562,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2017,85,Total,Units,%,Estimated value,Free,,12 to 23 months old
Niger,NE,NER,562,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2018,79,Total,Units,%,Estimated value,Free,,12 to 23 months old
Niger,NE,NER,562,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2019,81,Total,Units,%,Estimated value,Free,,12 to 23 months old
Niger,NE,NER,562,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2020,81,Total,Units,%,Estimated value,Free,,12 to 23 months old
Niger,NE,NER,562,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2021,82,Total,Units,%,Estimated value,Free,,12 to 23 months old
Niger,NE,NER,562,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2022,84,Total,Units,%,Estimated value,Free,,12 to 23 months old
Nigeria,NG,NGA,566,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2015,36,Total,Units,%,Estimated value,Free,,12 to 23 months old
Nigeria,NG,NGA,566,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2016,49,Total,Units,%,Estimated value,Free,,12 to 23 months old
Nigeria,NG,NGA,566,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2017,53,Total,Units,%,Estimated value,Free,,12 to 23 months old
Nigeria,NG,NGA,566,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2018,59,Total,Units,%,Estimated value,Free,,12 to 23 months old
Nigeria,NG,NGA,566,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2019,64,Total,Units,%,Estimated value,Free,,12 to 23 months old
Nigeria,NG,NGA,566,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2020,60,Total,Units,%,Estimated value,Free,,12 to 23 months old
Nigeria,NG,NGA,566,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2021,60,Total,Units,%,Estimated value,Free,,12 to 23 months old
Nigeria,NG,NGA,566,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2022,60,Total,Units,%,Estimated value,Free,,12 to 23 months old
Niue,NU,NIU,570,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2009,99,Total,Units,%,Estimated value,Free,,12 to 23 months old
Niue,NU,NIU,570,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2010,99,Total,Units,%,Estimated value,Free,,12 to 23 months old
Niue,NU,NIU,570,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2011,99,Total,Units,%,Estimated value,Free,,12 to 23 months old
Niue,NU,NIU,570,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2012,99,Total,Units,%,Estimated value,Free,,12 to 23 months old
Niue,NU,NIU,570,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2013,99,Total,Units,%,Estimated value,Free,,12 to 23 months old
Niue,NU,NIU,570,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2014,99,Total,Units,%,Estimated value,Free,,12 to 23 months old
Niue,NU,NIU,570,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2015,99,Total,Units,%,Estimated value,Free,,12 to 23 months old
Niue,NU,NIU,570,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2016,99,Total,Units,%,Estimated value,Free,,12 to 23 months old
Niue,NU,NIU,570,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2017,99,Total,Units,%,Estimated value,Free,,12 to 23 months old
Niue,NU,NIU,570,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2018,99,Total,Units,%,Estimated value,Free,,12 to 23 months old
Niue,NU,NIU,570,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2019,99,Total,Units,%,Estimated value,Free,,12 to 23 months old
Niue,NU,NIU,570,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2020,99,Total,Units,%,Estimated value,Free,,12 to 23 months old
Niue,NU,NIU,570,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2021,99,Total,Units,%,Estimated value,Free,,12 to 23 months old
Niue,NU,NIU,570,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2022,99,Total,Units,%,Estimated value,Free,,12 to 23 months old
"Macedonia, the former Yugoslav Republic of",MK,MKD,807,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2020,30,Total,Units,%,Estimated value,Free,,12 to 23 months old
"Macedonia, the former Yugoslav Republic of",MK,MKD,807,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2021,53,Total,Units,%,Estimated value,Free,,12 to 23 months old
"Macedonia, the former Yugoslav Republic of",MK,MKD,807,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2022,56,Total,Units,%,Estimated value,Free,,12 to 23 months old
Norway,NO,NOR,578,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2008,86,Total,Units,%,Estimated value,Free,,12 to 23 months old
Norway,NO,NOR,578,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2009,91,Total,Units,%,Estimated value,Free,,12 to 23 months old
Norway,NO,NOR,578,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2010,91,Total,Units,%,Estimated value,Free,,12 to 23 months old
Norway,NO,NOR,578,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2011,92,Total,Units,%,Estimated value,Free,,12 to 23 months old
Norway,NO,NOR,578,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2012,93,Total,Units,%,Estimated value,Free,,12 to 23 months old
Norway,NO,NOR,578,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2013,93,Total,Units,%,Estimated value,Free,,12 to 23 months old
Norway,NO,NOR,578,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2014,91,Total,Units,%,Estimated value,Free,,12 to 23 months old
Norway,NO,NOR,578,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2015,93,Total,Units,%,Estimated value,Free,,12 to 23 months old
Norway,NO,NOR,578,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2016,94,Total,Units,%,Estimated value,Free,,12 to 23 months old
Norway,NO,NOR,578,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2017,94,Total,Units,%,Estimated value,Free,,12 to 23 months old
Norway,NO,NOR,578,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2018,94,Total,Units,%,Estimated value,Free,,12 to 23 months old
Norway,NO,NOR,578,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2019,95,Total,Units,%,Estimated value,Free,,12 to 23 months old
Norway,NO,NOR,578,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2020,96,Total,Units,%,Estimated value,Free,,12 to 23 months old
Norway,NO,NOR,578,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2021,96,Total,Units,%,Estimated value,Free,,12 to 23 months old
Norway,NO,NOR,578,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2022,95,Total,Units,%,Estimated value,Free,,12 to 23 months old
Oman,OM,OMN,512,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2009,96,Total,Units,%,Estimated value,Free,,12 to 23 months old
Oman,OM,OMN,512,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2010,99,Total,Units,%,Estimated value,Free,,12 to 23 months old
Oman,OM,OMN,512,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2011,99,Total,Units,%,Estimated value,Free,,12 to 23 months old
Oman,OM,OMN,512,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2012,99,Total,Units,%,Estimated value,Free,,12 to 23 months old
Oman,OM,OMN,512,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2013,99,Total,Units,%,Estimated value,Free,,12 to 23 months old
Oman,OM,OMN,512,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2014,98,Total,Units,%,Estimated value,Free,,12 to 23 months old
Oman,OM,OMN,512,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2015,98,Total,Units,%,Estimated value,Free,,12 to 23 months old
Oman,OM,OMN,512,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2016,99,Total,Units,%,Estimated value,Free,,12 to 23 months old
Oman,OM,OMN,512,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2017,99,Total,Units,%,Estimated value,Free,,12 to 23 months old
Oman,OM,OMN,512,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2018,99,Total,Units,%,Estimated value,Free,,12 to 23 months old
Oman,OM,OMN,512,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2019,99,Total,Units,%,Estimated value,Free,,12 to 23 months old
Oman,OM,OMN,512,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2020,99,Total,Units,%,Estimated value,Free,,12 to 23 months old
Oman,OM,OMN,512,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2021,99,Total,Units,%,Estimated value,Free,,12 to 23 months old
Oman,OM,OMN,512,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2022,97,Total,Units,%,Estimated value,Free,,12 to 23 months old
Pakistan,PK,PAK,586,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2013,65,Total,Units,%,Estimated value,Free,,12 to 23 months old
Pakistan,PK,PAK,586,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2014,68,Total,Units,%,Estimated value,Free,,12 to 23 months old
Pakistan,PK,PAK,586,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2015,80,Total,Units,%,Estimated value,Free,,12 to 23 months old
Pakistan,PK,PAK,586,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2016,78,Total,Units,%,Estimated value,Free,,12 to 23 months old
Pakistan,PK,PAK,586,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2017,82,Total,Units,%,Estimated value,Free,,12 to 23 months old
Pakistan,PK,PAK,586,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2018,82,Total,Units,%,Estimated value,Free,,12 to 23 months old
Pakistan,PK,PAK,586,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2019,83,Total,Units,%,Estimated value,Free,,12 to 23 months old
Pakistan,PK,PAK,586,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2020,82,Total,Units,%,Estimated value,Free,,12 to 23 months old
Pakistan,PK,PAK,586,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2021,83,Total,Units,%,Estimated value,Free,,12 to 23 months old
Pakistan,PK,PAK,586,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2022,85,Total,Units,%,Estimated value,Free,,12 to 23 months old
Palau,PW,PLW,585,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2008,7,Total,Units,%,Estimated value,Free,,12 to 23 months old
Palau,PW,PLW,585,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2009,18,Total,Units,%,Estimated value,Free,,12 to 23 months old
Palau,PW,PLW,585,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2010,45,Total,Units,%,Estimated value,Free,,12 to 23 months old
Palau,PW,PLW,585,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2011,61,Total,Units,%,Estimated value,Free,,12 to 23 months old
Palau,PW,PLW,585,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2012,82,Total,Units,%,Estimated value,Free,,12 to 23 months old
Palau,PW,PLW,585,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2013,93,Total,Units,%,Estimated value,Free,,12 to 23 months old
Palau,PW,PLW,585,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2014,93,Total,Units,%,Estimated value,Free,,12 to 23 months old
Palau,PW,PLW,585,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2015,95,Total,Units,%,Estimated value,Free,,12 to 23 months old
Palau,PW,PLW,585,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2016,98,Total,Units,%,Estimated value,Free,,12 to 23 months old
Palau,PW,PLW,585,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2017,89,Total,Units,%,Estimated value,Free,,12 to 23 months old
Palau,PW,PLW,585,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2018,82,Total,Units,%,Estimated value,Free,,12 to 23 months old
Palau,PW,PLW,585,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2019,74,Total,Units,%,Estimated value,Free,,12 to 23 months old
Palau,PW,PLW,585,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2020,75,Total,Units,%,Estimated value,Free,,12 to 23 months old
Palau,PW,PLW,585,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2021,77,Total,Units,%,Estimated value,Free,,12 to 23 months old
Palau,PW,PLW,585,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2022,82,Total,Units,%,Estimated value,Free,,12 to 23 months old
Panama,PA,PAN,591,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2010,48,Total,Units,%,Estimated value,Free,,12 to 23 months old
Panama,PA,PAN,591,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2011,63,Total,Units,%,Estimated value,Free,,12 to 23 months old
Panama,PA,PAN,591,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2012,76,Total,Units,%,Estimated value,Free,,12 to 23 months old
Panama,PA,PAN,591,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2013,88,Total,Units,%,Estimated value,Free,,12 to 23 months old
Panama,PA,PAN,591,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2014,91,Total,Units,%,Estimated value,Free,,12 to 23 months old
Panama,PA,PAN,591,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2015,92,Total,Units,%,Estimated value,Free,,12 to 23 months old
Panama,PA,PAN,591,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2016,94,Total,Units,%,Estimated value,Free,,12 to 23 months old
Panama,PA,PAN,591,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2017,97,Total,Units,%,Estimated value,Free,,12 to 23 months old
Panama,PA,PAN,591,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2018,97,Total,Units,%,Estimated value,Free,,12 to 23 months old
Panama,PA,PAN,591,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2019,96,Total,Units,%,Estimated value,Free,,12 to 23 months old
Panama,PA,PAN,591,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2020,74,Total,Units,%,Estimated value,Free,,12 to 23 months old
Panama,PA,PAN,591,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2021,87,Total,Units,%,Estimated value,Free,,12 to 23 months old
Panama,PA,PAN,591,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2022,87,Total,Units,%,Estimated value,Free,,12 to 23 months old
Papua New Guinea,PG,PNG,598,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2015,20,Total,Units,%,Estimated value,Free,,12 to 23 months old
Papua New Guinea,PG,PNG,598,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2016,20,Total,Units,%,Estimated value,Free,,12 to 23 months old
Papua New Guinea,PG,PNG,598,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2017,36,Total,Units,%,Estimated value,Free,,12 to 23 months old
Papua New Guinea,PG,PNG,598,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2018,35,Total,Units,%,Estimated value,Free,,12 to 23 months old
Papua New Guinea,PG,PNG,598,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2019,35,Total,Units,%,Estimated value,Free,,12 to 23 months old
Papua New Guinea,PG,PNG,598,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2020,39,Total,Units,%,Estimated value,Free,,12 to 23 months old
Papua New Guinea,PG,PNG,598,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2021,32,Total,Units,%,Estimated value,Free,,12 to 23 months old
Papua New Guinea,PG,PNG,598,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2022,35,Total,Units,%,Estimated value,Free,,12 to 23 months old
Paraguay,PY,PRY,600,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2012,82,Total,Units,%,Estimated value,Free,,12 to 23 months old
Paraguay,PY,PRY,600,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2013,90,Total,Units,%,Estimated value,Free,,12 to 23 months old
Paraguay,PY,PRY,600,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2014,86,Total,Units,%,Estimated value,Free,,12 to 23 months old
Paraguay,PY,PRY,600,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2015,90,Total,Units,%,Estimated value,Free,,12 to 23 months old
Paraguay,PY,PRY,600,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2016,99,Total,Units,%,Estimated value,Free,,12 to 23 months old
Paraguay,PY,PRY,600,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2017,93,Total,Units,%,Estimated value,Free,,12 to 23 months old
Paraguay,PY,PRY,600,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2018,94,Total,Units,%,Estimated value,Free,,12 to 23 months old
Paraguay,PY,PRY,600,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2019,89,Total,Units,%,Estimated value,Free,,12 to 23 months old
Paraguay,PY,PRY,600,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2020,82,Total,Units,%,Estimated value,Free,,12 to 23 months old
Paraguay,PY,PRY,600,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2021,62,Total,Units,%,Estimated value,Free,,12 to 23 months old
Paraguay,PY,PRY,600,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2022,74,Total,Units,%,Estimated value,Free,,12 to 23 months old
Peru,PE,PER,604,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2009,9,Total,Units,%,Estimated value,Free,,12 to 23 months old
Peru,PE,PER,604,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2010,83,Total,Units,%,Estimated value,Free,,12 to 23 months old
Peru,PE,PER,604,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2011,82,Total,Units,%,Estimated value,Free,,12 to 23 months old
Peru,PE,PER,604,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2012,89,Total,Units,%,Estimated value,Free,,12 to 23 months old
Peru,PE,PER,604,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2013,85,Total,Units,%,Estimated value,Free,,12 to 23 months old
Peru,PE,PER,604,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2014,86,Total,Units,%,Estimated value,Free,,12 to 23 months old
Peru,PE,PER,604,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2015,90,Total,Units,%,Estimated value,Free,,12 to 23 months old
Peru,PE,PER,604,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2016,86,Total,Units,%,Estimated value,Free,,12 to 23 months old
Peru,PE,PER,604,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2017,84,Total,Units,%,Estimated value,Free,,12 to 23 months old
Peru,PE,PER,604,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2018,82,Total,Units,%,Estimated value,Free,,12 to 23 months old
Peru,PE,PER,604,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2019,80,Total,Units,%,Estimated value,Free,,12 to 23 months old
Peru,PE,PER,604,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2020,74,Total,Units,%,Estimated value,Free,,12 to 23 months old
Peru,PE,PER,604,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2021,75,Total,Units,%,Estimated value,Free,,12 to 23 months old
Peru,PE,PER,604,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2022,71,Total,Units,%,Estimated value,Free,,12 to 23 months old
Philippines,PH,PHL,608,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2014,35,Total,Units,%,Estimated value,Free,,12 to 23 months old
Philippines,PH,PHL,608,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2015,18,Total,Units,%,Estimated value,Free,,12 to 23 months old
Philippines,PH,PHL,608,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2016,36,Total,Units,%,Estimated value,Free,,12 to 23 months old
Philippines,PH,PHL,608,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2017,33,Total,Units,%,Estimated value,Free,,12 to 23 months old
Philippines,PH,PHL,608,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2018,43,Total,Units,%,Estimated value,Free,,12 to 23 months old
Philippines,PH,PHL,608,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2019,53,Total,Units,%,Estimated value,Free,,12 to 23 months old
Philippines,PH,PHL,608,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2020,66,Total,Units,%,Estimated value,Free,,12 to 23 months old
Philippines,PH,PHL,608,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2021,51,Total,Units,%,Estimated value,Free,,12 to 23 months old
Philippines,PH,PHL,608,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2022,71,Total,Units,%,Estimated value,Free,,12 to 23 months old
Poland,PL,POL,616,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2018,60,Total,Units,%,Estimated value,Free,,12 to 23 months old
Poland,PL,POL,616,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2019,60,Total,Units,%,Estimated value,Free,,12 to 23 months old
Poland,PL,POL,616,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2020,62,Total,Units,%,Estimated value,Free,,12 to 23 months old
Poland,PL,POL,616,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2021,61,Total,Units,%,Estimated value,Free,,12 to 23 months old
Poland,PL,POL,616,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2022,61,Total,Units,%,Estimated value,Free,,12 to 23 months old
Portugal,PT,PRT,620,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2016,73,Total,Units,%,Estimated value,Free,,12 to 23 months old
Portugal,PT,PRT,620,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2017,96,Total,Units,%,Estimated value,Free,,12 to 23 months old
Portugal,PT,PRT,620,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2018,98,Total,Units,%,Estimated value,Free,,12 to 23 months old
Portugal,PT,PRT,620,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2019,98,Total,Units,%,Estimated value,Free,,12 to 23 months old
Portugal,PT,PRT,620,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2020,98,Total,Units,%,Estimated value,Free,,12 to 23 months old
Portugal,PT,PRT,620,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2021,98,Total,Units,%,Estimated value,Free,,12 to 23 months old
Portugal,PT,PRT,620,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2022,98,Total,Units,%,Estimated value,Free,,12 to 23 months old
Qatar,QA,QAT,634,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2009,99,Total,Units,%,Estimated value,Free,,12 to 23 months old
Qatar,QA,QAT,634,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2010,97,Total,Units,%,Estimated value,Free,,12 to 23 months old
Qatar,QA,QAT,634,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2011,98,Total,Units,%,Estimated value,Free,,12 to 23 months old
Qatar,QA,QAT,634,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2012,92,Total,Units,%,Estimated value,Free,,12 to 23 months old
Qatar,QA,QAT,634,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2013,99,Total,Units,%,Estimated value,Free,,12 to 23 months old
Qatar,QA,QAT,634,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2014,94,Total,Units,%,Estimated value,Free,,12 to 23 months old
Qatar,QA,QAT,634,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2015,95,Total,Units,%,Estimated value,Free,,12 to 23 months old
Qatar,QA,QAT,634,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2016,97,Total,Units,%,Estimated value,Free,,12 to 23 months old
Qatar,QA,QAT,634,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2017,98,Total,Units,%,Estimated value,Free,,12 to 23 months old
Qatar,QA,QAT,634,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2018,98,Total,Units,%,Estimated value,Free,,12 to 23 months old
Qatar,QA,QAT,634,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2019,98,Total,Units,%,Estimated value,Free,,12 to 23 months old
Qatar,QA,QAT,634,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2020,98,Total,Units,%,Estimated value,Free,,12 to 23 months old
Qatar,QA,QAT,634,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2021,98,Total,Units,%,Estimated value,Free,,12 to 23 months old
Qatar,QA,QAT,634,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2022,97,Total,Units,%,Estimated value,Free,,12 to 23 months old
"Korea, Republic of",KR,KOR,410,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2015,97,Total,Units,%,Estimated value,Free,,12 to 23 months old
South Korea,KR,KOR,410,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2015,97,Total,Units,%,Estimated value,Free,,12 to 23 months old
"Korea, Republic of",KR,KOR,410,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2016,98,Total,Units,%,Estimated value,Free,,12 to 23 months old
South Korea,KR,KOR,410,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2016,98,Total,Units,%,Estimated value,Free,,12 to 23 months old
"Korea, Republic of",KR,KOR,410,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2017,97,Total,Units,%,Estimated value,Free,,12 to 23 months old
South Korea,KR,KOR,410,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2017,97,Total,Units,%,Estimated value,Free,,12 to 23 months old
"Korea, Republic of",KR,KOR,410,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2018,97,Total,Units,%,Estimated value,Free,,12 to 23 months old
South Korea,KR,KOR,410,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2018,97,Total,Units,%,Estimated value,Free,,12 to 23 months old
"Korea, Republic of",KR,KOR,410,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2019,98,Total,Units,%,Estimated value,Free,,12 to 23 months old
South Korea,KR,KOR,410,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2019,98,Total,Units,%,Estimated value,Free,,12 to 23 months old
"Korea, Republic of",KR,KOR,410,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2020,97,Total,Units,%,Estimated value,Free,,12 to 23 months old
South Korea,KR,KOR,410,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2020,97,Total,Units,%,Estimated value,Free,,12 to 23 months old
"Korea, Republic of",KR,KOR,410,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2021,97,Total,Units,%,Estimated value,Free,,12 to 23 months old
South Korea,KR,KOR,410,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2021,97,Total,Units,%,Estimated value,Free,,12 to 23 months old
"Korea, Republic of",KR,KOR,410,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2022,97,Total,Units,%,Estimated value,Free,,12 to 23 months old
South Korea,KR,KOR,410,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2022,97,Total,Units,%,Estimated value,Free,,12 to 23 months old
"Moldova, Republic of",MD,MDA,498,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2013,1,Total,Units,%,Estimated value,Free,,12 to 23 months old
"Moldova, Republic of",MD,MDA,498,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2014,28,Total,Units,%,Estimated value,Free,,12 to 23 months old
"Moldova, Republic of",MD,MDA,498,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2015,72,Total,Units,%,Estimated value,Free,,12 to 23 months old
"Moldova, Republic of",MD,MDA,498,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2016,77,Total,Units,%,Estimated value,Free,,12 to 23 months old
"Moldova, Republic of",MD,MDA,498,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2017,79,Total,Units,%,Estimated value,Free,,12 to 23 months old
"Moldova, Republic of",MD,MDA,498,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2018,85,Total,Units,%,Estimated value,Free,,12 to 23 months old
"Moldova, Republic of",MD,MDA,498,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2019,80,Total,Units,%,Estimated value,Free,,12 to 23 months old
"Moldova, Republic of",MD,MDA,498,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2020,72,Total,Units,%,Estimated value,Free,,12 to 23 months old
"Moldova, Republic of",MD,MDA,498,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2021,78,Total,Units,%,Estimated value,Free,,12 to 23 months old
"Moldova, Republic of",MD,MDA,498,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2022,79,Total,Units,%,Estimated value,Free,,12 to 23 months old
Romania,RO,ROU,642,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2019,88,Total,Units,%,Estimated value,Free,,12 to 23 months old
Romania,RO,ROU,642,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2020,85,Total,Units,%,Estimated value,Free,,12 to 23 months old
Romania,RO,ROU,642,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2021,85,Total,Units,%,Estimated value,Free,,12 to 23 months old
Romania,RO,ROU,642,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2022,85,Total,Units,%,Estimated value,Free,,12 to 23 months old
Russian Federation,RU,RUS,643,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2016,35,Total,Units,%,Estimated value,Free,,12 to 23 months old
Russia,RU,RUS,643,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2016,35,Total,Units,%,Estimated value,Free,,12 to 23 months old
Russian Federation,RU,RUS,643,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2017,70,Total,Units,%,Estimated value,Free,,12 to 23 months old
Russia,RU,RUS,643,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2017,70,Total,Units,%,Estimated value,Free,,12 to 23 months old
Russian Federation,RU,RUS,643,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2018,82,Total,Units,%,Estimated value,Free,,12 to 23 months old
Russia,RU,RUS,643,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2018,82,Total,Units,%,Estimated value,Free,,12 to 23 months old
Russian Federation,RU,RUS,643,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2019,85,Total,Units,%,Estimated value,Free,,12 to 23 months old
Russia,RU,RUS,643,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2019,85,Total,Units,%,Estimated value,Free,,12 to 23 months old
Russian Federation,RU,RUS,643,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2020,87,Total,Units,%,Estimated value,Free,,12 to 23 months old
Russia,RU,RUS,643,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2020,87,Total,Units,%,Estimated value,Free,,12 to 23 months old
Russian Federation,RU,RUS,643,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2021,89,Total,Units,%,Estimated value,Free,,12 to 23 months old
Russia,RU,RUS,643,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2021,89,Total,Units,%,Estimated value,Free,,12 to 23 months old
Russian Federation,RU,RUS,643,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2022,92,Total,Units,%,Estimated value,Free,,12 to 23 months old
Russia,RU,RUS,643,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2022,92,Total,Units,%,Estimated value,Free,,12 to 23 months old
Rwanda,RW,RWA,646,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2010,97,Total,Units,%,Estimated value,Free,,12 to 23 months old
Rwanda,RW,RWA,646,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2011,97,Total,Units,%,Estimated value,Free,,12 to 23 months old
Rwanda,RW,RWA,646,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2012,98,Total,Units,%,Estimated value,Free,,12 to 23 months old
Rwanda,RW,RWA,646,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2013,98,Total,Units,%,Estimated value,Free,,12 to 23 months old
Rwanda,RW,RWA,646,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2014,98,Total,Units,%,Estimated value,Free,,12 to 23 months old
Rwanda,RW,RWA,646,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2015,98,Total,Units,%,Estimated value,Free,,12 to 23 months old
Rwanda,RW,RWA,646,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2016,98,Total,Units,%,Estimated value,Free,,12 to 23 months old
Rwanda,RW,RWA,646,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2017,98,Total,Units,%,Estimated value,Free,,12 to 23 months old
Rwanda,RW,RWA,646,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2018,97,Total,Units,%,Estimated value,Free,,12 to 23 months old
Rwanda,RW,RWA,646,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2019,98,Total,Units,%,Estimated value,Free,,12 to 23 months old
Rwanda,RW,RWA,646,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2020,91,Total,Units,%,Estimated value,Free,,12 to 23 months old
Rwanda,RW,RWA,646,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2021,88,Total,Units,%,Estimated value,Free,,12 to 23 months old
Rwanda,RW,RWA,646,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2022,98,Total,Units,%,Estimated value,Free,,12 to 23 months old
Samoa,WS,WSM,882,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2021,3,Total,Units,%,Estimated value,Free,,12 to 23 months old
Samoa,WS,WSM,882,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2022,36,Total,Units,%,Estimated value,Free,,12 to 23 months old
San Marino,SM,SMR,674,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2016,53,Total,Units,%,Estimated value,Free,,12 to 23 months old
San Marino,SM,SMR,674,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2017,56,Total,Units,%,Estimated value,Free,,12 to 23 months old
San Marino,SM,SMR,674,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2018,58,Total,Units,%,Estimated value,Free,,12 to 23 months old
San Marino,SM,SMR,674,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2019,76,Total,Units,%,Estimated value,Free,,12 to 23 months old
San Marino,SM,SMR,674,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2020,82,Total,Units,%,Estimated value,Free,,12 to 23 months old
San Marino,SM,SMR,674,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2021,82,Total,Units,%,Estimated value,Free,,12 to 23 months old
San Marino,SM,SMR,674,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2022,80,Total,Units,%,Estimated value,Free,,12 to 23 months old
Sao Tome and Principe,ST,STP,678,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2013,97,Total,Units,%,Estimated value,Free,,12 to 23 months old
Sao Tome and Principe,ST,STP,678,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2014,95,Total,Units,%,Estimated value,Free,,12 to 23 months old
Sao Tome and Principe,ST,STP,678,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2015,96,Total,Units,%,Estimated value,Free,,12 to 23 months old
Sao Tome and Principe,ST,STP,678,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2016,96,Total,Units,%,Estimated value,Free,,12 to 23 months old
Sao Tome and Principe,ST,STP,678,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2017,95,Total,Units,%,Estimated value,Free,,12 to 23 months old
Sao Tome and Principe,ST,STP,678,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2018,95,Total,Units,%,Estimated value,Free,,12 to 23 months old
Sao Tome and Principe,ST,STP,678,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2019,95,Total,Units,%,Estimated value,Free,,12 to 23 months old
Sao Tome and Principe,ST,STP,678,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2020,96,Total,Units,%,Estimated value,Free,,12 to 23 months old
Sao Tome and Principe,ST,STP,678,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2021,97,Total,Units,%,Estimated value,Free,,12 to 23 months old
Sao Tome and Principe,ST,STP,678,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2022,97,Total,Units,%,Estimated value,Free,,12 to 23 months old
Saudi Arabia,SA,SAU,682,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2009,98,Total,Units,%,Estimated value,Free,,12 to 23 months old
Saudi Arabia,SA,SAU,682,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2010,98,Total,Units,%,Estimated value,Free,,12 to 23 months old
Saudi Arabia,SA,SAU,682,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2011,98,Total,Units,%,Estimated value,Free,,12 to 23 months old
Saudi Arabia,SA,SAU,682,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2012,98,Total,Units,%,Estimated value,Free,,12 to 23 months old
Saudi Arabia,SA,SAU,682,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2013,98,Total,Units,%,Estimated value,Free,,12 to 23 months old
Saudi Arabia,SA,SAU,682,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2014,98,Total,Units,%,Estimated value,Free,,12 to 23 months old
Saudi Arabia,SA,SAU,682,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2015,98,Total,Units,%,Estimated value,Free,,12 to 23 months old
Saudi Arabia,SA,SAU,682,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2016,98,Total,Units,%,Estimated value,Free,,12 to 23 months old
Saudi Arabia,SA,SAU,682,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2017,98,Total,Units,%,Estimated value,Free,,12 to 23 months old
Saudi Arabia,SA,SAU,682,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2018,98,Total,Units,%,Estimated value,Free,,12 to 23 months old
Saudi Arabia,SA,SAU,682,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2019,96,Total,Units,%,Estimated value,Free,,12 to 23 months old
Saudi Arabia,SA,SAU,682,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2020,95,Total,Units,%,Estimated value,Free,,12 to 23 months old
Saudi Arabia,SA,SAU,682,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2021,97,Total,Units,%,Estimated value,Free,,12 to 23 months old
Saudi Arabia,SA,SAU,682,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2022,98,Total,Units,%,Estimated value,Free,,12 to 23 months old
Senegal,SN,SEN,686,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2014,81,Total,Units,%,Estimated value,Free,,12 to 23 months old
Senegal,SN,SEN,686,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2015,89,Total,Units,%,Estimated value,Free,,12 to 23 months old
Senegal,SN,SEN,686,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2016,93,Total,Units,%,Estimated value,Free,,12 to 23 months old
Senegal,SN,SEN,686,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2017,92,Total,Units,%,Estimated value,Free,,12 to 23 months old
Senegal,SN,SEN,686,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2018,92,Total,Units,%,Estimated value,Free,,12 to 23 months old
Senegal,SN,SEN,686,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2019,96,Total,Units,%,Estimated value,Free,,12 to 23 months old
Senegal,SN,SEN,686,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2020,92,Total,Units,%,Estimated value,Free,,12 to 23 months old
Senegal,SN,SEN,686,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2021,86,Total,Units,%,Estimated value,Free,,12 to 23 months old
Senegal,SN,SEN,686,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2022,88,Total,Units,%,Estimated value,Free,,12 to 23 months old
Serbia,RS,SRB,688,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2018,67,Total,Units,%,Estimated value,Free,,12 to 23 months old
Serbia,RS,SRB,688,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2019,92,Total,Units,%,Estimated value,Free,,12 to 23 months old
Serbia,RS,SRB,688,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2020,87,Total,Units,%,Estimated value,Free,,12 to 23 months old
Serbia,RS,SRB,688,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2021,88,Total,Units,%,Estimated value,Free,,12 to 23 months old
Serbia,RS,SRB,688,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2022,89,Total,Units,%,Estimated value,Free,,12 to 23 months old
Seychelles,SC,SYC,690,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2018,16,Total,Units,%,Estimated value,Free,,12 to 23 months old
Seychelles,SC,SYC,690,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2019,92,Total,Units,%,Estimated value,Free,,12 to 23 months old
Seychelles,SC,SYC,690,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2020,94,Total,Units,%,Estimated value,Free,,12 to 23 months old
Seychelles,SC,SYC,690,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2021,95,Total,Units,%,Estimated value,Free,,12 to 23 months old
Seychelles,SC,SYC,690,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2022,97,Total,Units,%,Estimated value,Free,,12 to 23 months old
Sierra Leone,SL,SLE,694,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2011,75,Total,Units,%,Estimated value,Free,,12 to 23 months old
Sierra Leone,SL,SLE,694,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2012,92,Total,Units,%,Estimated value,Free,,12 to 23 months old
Sierra Leone,SL,SLE,694,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2013,92,Total,Units,%,Estimated value,Free,,12 to 23 months old
Sierra Leone,SL,SLE,694,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2014,83,Total,Units,%,Estimated value,Free,,12 to 23 months old
Sierra Leone,SL,SLE,694,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2015,86,Total,Units,%,Estimated value,Free,,12 to 23 months old
Sierra Leone,SL,SLE,694,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2016,84,Total,Units,%,Estimated value,Free,,12 to 23 months old
Sierra Leone,SL,SLE,694,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2017,90,Total,Units,%,Estimated value,Free,,12 to 23 months old
Sierra Leone,SL,SLE,694,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2018,92,Total,Units,%,Estimated value,Free,,12 to 23 months old
Sierra Leone,SL,SLE,694,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2019,94,Total,Units,%,Estimated value,Free,,12 to 23 months old
Sierra Leone,SL,SLE,694,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2020,91,Total,Units,%,Estimated value,Free,,12 to 23 months old
Sierra Leone,SL,SLE,694,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2021,90,Total,Units,%,Estimated value,Free,,12 to 23 months old
Sierra Leone,SL,SLE,694,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2022,93,Total,Units,%,Estimated value,Free,,12 to 23 months old
Singapore,SG,SGP,702,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2009,17,Total,Units,%,Estimated value,Free,,12 to 23 months old
Singapore,SG,SGP,702,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2010,22,Total,Units,%,Estimated value,Free,,12 to 23 months old
Singapore,SG,SGP,702,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2011,40,Total,Units,%,Estimated value,Free,,12 to 23 months old
Singapore,SG,SGP,702,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2012,52,Total,Units,%,Estimated value,Free,,12 to 23 months old
Singapore,SG,SGP,702,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2013,60,Total,Units,%,Estimated value,Free,,12 to 23 months old
Singapore,SG,SGP,702,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2014,68,Total,Units,%,Estimated value,Free,,12 to 23 months old
Singapore,SG,SGP,702,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2015,75,Total,Units,%,Estimated value,Free,,12 to 23 months old
Singapore,SG,SGP,702,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2016,78,Total,Units,%,Estimated value,Free,,12 to 23 months old
Singapore,SG,SGP,702,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2017,83,Total,Units,%,Estimated value,Free,,12 to 23 months old
Singapore,SG,SGP,702,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2018,84,Total,Units,%,Estimated value,Free,,12 to 23 months old
Singapore,SG,SGP,702,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2019,84,Total,Units,%,Estimated value,Free,,12 to 23 months old
Singapore,SG,SGP,702,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2020,87,Total,Units,%,Estimated value,Free,,12 to 23 months old
Singapore,SG,SGP,702,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2021,88,Total,Units,%,Estimated value,Free,,12 to 23 months old
Singapore,SG,SGP,702,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2022,90,Total,Units,%,Estimated value,Free,,12 to 23 months old
Slovakia,SK,SVK,703,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2009,99,Total,Units,%,Estimated value,Free,,12 to 23 months old
Slovakia,SK,SVK,703,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2010,99,Total,Units,%,Estimated value,Free,,12 to 23 months old
Slovakia,SK,SVK,703,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2011,99,Total,Units,%,Estimated value,Free,,12 to 23 months old
Slovakia,SK,SVK,703,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2012,99,Total,Units,%,Estimated value,Free,,12 to 23 months old
Slovakia,SK,SVK,703,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2013,98,Total,Units,%,Estimated value,Free,,12 to 23 months old
Slovakia,SK,SVK,703,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2014,96,Total,Units,%,Estimated value,Free,,12 to 23 months old
Slovakia,SK,SVK,703,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2015,96,Total,Units,%,Estimated value,Free,,12 to 23 months old
Slovakia,SK,SVK,703,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2016,96,Total,Units,%,Estimated value,Free,,12 to 23 months old
Slovakia,SK,SVK,703,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2017,96,Total,Units,%,Estimated value,Free,,12 to 23 months old
Slovakia,SK,SVK,703,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2018,96,Total,Units,%,Estimated value,Free,,12 to 23 months old
Slovakia,SK,SVK,703,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2019,96,Total,Units,%,Estimated value,Free,,12 to 23 months old
Slovakia,SK,SVK,703,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2020,96,Total,Units,%,Estimated value,Free,,12 to 23 months old
Slovakia,SK,SVK,703,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2021,97,Total,Units,%,Estimated value,Free,,12 to 23 months old
Slovakia,SK,SVK,703,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2022,96,Total,Units,%,Estimated value,Free,,12 to 23 months old
Slovenia,SI,SVN,705,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2015,49,Total,Units,%,Estimated value,Free,,12 to 23 months old
Slovenia,SI,SVN,705,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2016,49,Total,Units,%,Estimated value,Free,,12 to 23 months old
Slovenia,SI,SVN,705,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2017,55,Total,Units,%,Estimated value,Free,,12 to 23 months old
Slovenia,SI,SVN,705,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2018,60,Total,Units,%,Estimated value,Free,,12 to 23 months old
Slovenia,SI,SVN,705,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2019,65,Total,Units,%,Estimated value,Free,,12 to 23 months old
Slovenia,SI,SVN,705,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2020,70,Total,Units,%,Estimated value,Free,,12 to 23 months old
Slovenia,SI,SVN,705,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2021,58,Total,Units,%,Estimated value,Free,,12 to 23 months old
Slovenia,SI,SVN,705,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2022,61,Total,Units,%,Estimated value,Free,,12 to 23 months old
Solomon Islands,SB,SLB,90,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2015,42,Total,Units,%,Estimated value,Free,,12 to 23 months old
Solomon Islands,SB,SLB,90,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2016,87,Total,Units,%,Estimated value,Free,,12 to 23 months old
Solomon Islands,SB,SLB,90,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2017,81,Total,Units,%,Estimated value,Free,,12 to 23 months old
Solomon Islands,SB,SLB,90,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2018,84,Total,Units,%,Estimated value,Free,,12 to 23 months old
Solomon Islands,SB,SLB,90,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2019,94,Total,Units,%,Estimated value,Free,,12 to 23 months old
Solomon Islands,SB,SLB,90,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2020,93,Total,Units,%,Estimated value,Free,,12 to 23 months old
Solomon Islands,SB,SLB,90,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2021,86,Total,Units,%,Estimated value,Free,,12 to 23 months old
Solomon Islands,SB,SLB,90,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2022,89,Total,Units,%,Estimated value,Free,,12 to 23 months old
South Africa,ZA,ZAF,710,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2009,10,Total,Units,%,Estimated value,Free,,12 to 23 months old
South Africa,ZA,ZAF,710,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2010,58,Total,Units,%,Estimated value,Free,,12 to 23 months old
South Africa,ZA,ZAF,710,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2011,62,Total,Units,%,Estimated value,Free,,12 to 23 months old
South Africa,ZA,ZAF,710,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2012,75,Total,Units,%,Estimated value,Free,,12 to 23 months old
South Africa,ZA,ZAF,710,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2013,77,Total,Units,%,Estimated value,Free,,12 to 23 months old
South Africa,ZA,ZAF,710,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2014,85,Total,Units,%,Estimated value,Free,,12 to 23 months old
South Africa,ZA,ZAF,710,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2015,85,Total,Units,%,Estimated value,Free,,12 to 23 months old
South Africa,ZA,ZAF,710,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2016,82,Total,Units,%,Estimated value,Free,,12 to 23 months old
South Africa,ZA,ZAF,710,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2017,78,Total,Units,%,Estimated value,Free,,12 to 23 months old
South Africa,ZA,ZAF,710,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2018,83,Total,Units,%,Estimated value,Free,,12 to 23 months old
South Africa,ZA,ZAF,710,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2019,86,Total,Units,%,Estimated value,Free,,12 to 23 months old
South Africa,ZA,ZAF,710,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2020,83,Total,Units,%,Estimated value,Free,,12 to 23 months old
South Africa,ZA,ZAF,710,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2021,87,Total,Units,%,Estimated value,Free,,12 to 23 months old
South Africa,ZA,ZAF,710,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2022,89,Total,Units,%,Estimated value,Free,,12 to 23 months old
Spain,ES,ESP,724,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2017,88,Total,Units,%,Estimated value,Free,,12 to 23 months old
Spain,ES,ESP,724,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2018,95,Total,Units,%,Estimated value,Free,,12 to 23 months old
Spain,ES,ESP,724,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2019,94,Total,Units,%,Estimated value,Free,,12 to 23 months old
Spain,ES,ESP,724,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2020,94,Total,Units,%,Estimated value,Free,,12 to 23 months old
Spain,ES,ESP,724,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2021,92,Total,Units,%,Estimated value,Free,,12 to 23 months old
Spain,ES,ESP,724,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2022,92,Total,Units,%,Estimated value,Free,,12 to 23 months old
"Palestinian Territory, Occupied",PS,PSE,275,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2012,25,Total,Units,%,Estimated value,Free,,12 to 23 months old
"Palestinian Territory, Occupied",PS,PSE,275,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2013,97,Total,Units,%,Estimated value,Free,,12 to 23 months old
"Palestinian Territory, Occupied",PS,PSE,275,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2014,99,Total,Units,%,Estimated value,Free,,12 to 23 months old
"Palestinian Territory, Occupied",PS,PSE,275,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2015,99,Total,Units,%,Estimated value,Free,,12 to 23 months old
"Palestinian Territory, Occupied",PS,PSE,275,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2016,99,Total,Units,%,Estimated value,Free,,12 to 23 months old
"Palestinian Territory, Occupied",PS,PSE,275,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2017,99,Total,Units,%,Estimated value,Free,,12 to 23 months old
"Palestinian Territory, Occupied",PS,PSE,275,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2018,96,Total,Units,%,Estimated value,Free,,12 to 23 months old
"Palestinian Territory, Occupied",PS,PSE,275,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2019,99,Total,Units,%,Estimated value,Free,,12 to 23 months old
"Palestinian Territory, Occupied",PS,PSE,275,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2020,98,Total,Units,%,Estimated value,Free,,12 to 23 months old
"Palestinian Territory, Occupied",PS,PSE,275,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2021,95,Total,Units,%,Estimated value,Free,,12 to 23 months old
"Palestinian Territory, Occupied",PS,PSE,275,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2022,99,Total,Units,%,Estimated value,Free,,12 to 23 months old
Sudan,SD,SDN,736,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2013,30,Total,Units,%,Estimated value,Free,,12 to 23 months old
Sudan,SD,SDN,736,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2014,97,Total,Units,%,Estimated value,Free,,12 to 23 months old
Sudan,SD,SDN,736,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2015,93,Total,Units,%,Estimated value,Free,,12 to 23 months old
Sudan,SD,SDN,736,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2016,93,Total,Units,%,Estimated value,Free,,12 to 23 months old
Sudan,SD,SDN,736,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2017,95,Total,Units,%,Estimated value,Free,,12 to 23 months old
Sudan,SD,SDN,736,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2018,93,Total,Units,%,Estimated value,Free,,12 to 23 months old
Sudan,SD,SDN,736,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2019,93,Total,Units,%,Estimated value,Free,,12 to 23 months old
Sudan,SD,SDN,736,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2020,90,Total,Units,%,Estimated value,Free,,12 to 23 months old
Sudan,SD,SDN,736,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2021,85,Total,Units,%,Estimated value,Free,,12 to 23 months old
Sudan,SD,SDN,736,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2022,85,Total,Units,%,Estimated value,Free,,12 to 23 months old
Sweden,SE,SWE,752,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2008,60,Total,Units,%,Estimated value,Free,,12 to 23 months old
Sweden,SE,SWE,752,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2009,98,Total,Units,%,Estimated value,Free,,12 to 23 months old
Sweden,SE,SWE,752,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2010,98,Total,Units,%,Estimated value,Free,,12 to 23 months old
Sweden,SE,SWE,752,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2011,98,Total,Units,%,Estimated value,Free,,12 to 23 months old
Sweden,SE,SWE,752,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2012,97,Total,Units,%,Estimated value,Free,,12 to 23 months old
Sweden,SE,SWE,752,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2013,97,Total,Units,%,Estimated value,Free,,12 to 23 months old
Sweden,SE,SWE,752,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2014,96,Total,Units,%,Estimated value,Free,,12 to 23 months old
Sweden,SE,SWE,752,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2015,97,Total,Units,%,Estimated value,Free,,12 to 23 months old
Sweden,SE,SWE,752,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2016,97,Total,Units,%,Estimated value,Free,,12 to 23 months old
Sweden,SE,SWE,752,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2017,97,Total,Units,%,Estimated value,Free,,12 to 23 months old
Sweden,SE,SWE,752,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2018,97,Total,Units,%,Estimated value,Free,,12 to 23 months old
Sweden,SE,SWE,752,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2019,97,Total,Units,%,Estimated value,Free,,12 to 23 months old
Sweden,SE,SWE,752,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2020,97,Total,Units,%,Estimated value,Free,,12 to 23 months old
Sweden,SE,SWE,752,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2021,97,Total,Units,%,Estimated value,Free,,12 to 23 months old
Sweden,SE,SWE,752,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2022,94,Total,Units,%,Estimated value,Free,,12 to 23 months old
Switzerland,CH,CHE,756,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2008,13,Total,Units,%,Estimated value,Free,,12 to 23 months old
Switzerland,CH,CHE,756,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2009,25,Total,Units,%,Estimated value,Free,,12 to 23 months old
Switzerland,CH,CHE,756,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2010,37,Total,Units,%,Estimated value,Free,,12 to 23 months old
Switzerland,CH,CHE,756,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2011,50,Total,Units,%,Estimated value,Free,,12 to 23 months old
Switzerland,CH,CHE,756,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2012,62,Total,Units,%,Estimated value,Free,,12 to 23 months old
Switzerland,CH,CHE,756,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2013,75,Total,Units,%,Estimated value,Free,,12 to 23 months old
Switzerland,CH,CHE,756,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2014,80,Total,Units,%,Estimated value,Free,,12 to 23 months old
Switzerland,CH,CHE,756,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2015,80,Total,Units,%,Estimated value,Free,,12 to 23 months old
Switzerland,CH,CHE,756,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2016,80,Total,Units,%,Estimated value,Free,,12 to 23 months old
Switzerland,CH,CHE,756,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2017,84,Total,Units,%,Estimated value,Free,,12 to 23 months old
Switzerland,CH,CHE,756,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2018,84,Total,Units,%,Estimated value,Free,,12 to 23 months old
Switzerland,CH,CHE,756,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2019,84,Total,Units,%,Estimated value,Free,,12 to 23 months old
Switzerland,CH,CHE,756,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2020,86,Total,Units,%,Estimated value,Free,,12 to 23 months old
Switzerland,CH,CHE,756,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2021,88,Total,Units,%,Estimated value,Free,,12 to 23 months old
Switzerland,CH,CHE,756,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2022,89,Total,Units,%,Estimated value,Free,,12 to 23 months old
Togo,TG,TGO,768,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2014,25,Total,Units,%,Estimated value,Free,,12 to 23 months old
Togo,TG,TGO,768,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2015,77,Total,Units,%,Estimated value,Free,,12 to 23 months old
Togo,TG,TGO,768,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2016,82,Total,Units,%,Estimated value,Free,,12 to 23 months old
Togo,TG,TGO,768,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2017,83,Total,Units,%,Estimated value,Free,,12 to 23 months old
Togo,TG,TGO,768,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2018,81,Total,Units,%,Estimated value,Free,,12 to 23 months old
Togo,TG,TGO,768,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2019,83,Total,Units,%,Estimated value,Free,,12 to 23 months old
Togo,TG,TGO,768,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2020,82,Total,Units,%,Estimated value,Free,,12 to 23 months old
Togo,TG,TGO,768,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2021,83,Total,Units,%,Estimated value,Free,,12 to 23 months old
Togo,TG,TGO,768,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2022,82,Total,Units,%,Estimated value,Free,,12 to 23 months old
Tonga,TO,TON,776,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2021,67,Total,Units,%,Estimated value,Free,,12 to 23 months old
Tonga,TO,TON,776,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2022,67,Total,Units,%,Estimated value,Free,,12 to 23 months old
Trinidad and Tobago,TT,TTO,780,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2012,39,Total,Units,%,Estimated value,Free,,12 to 23 months old
Trinidad and Tobago,TT,TTO,780,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2013,80,Total,Units,%,Estimated value,Free,,12 to 23 months old
Trinidad and Tobago,TT,TTO,780,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2014,95,Total,Units,%,Estimated value,Free,,12 to 23 months old
Trinidad and Tobago,TT,TTO,780,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2015,93,Total,Units,%,Estimated value,Free,,12 to 23 months old
Trinidad and Tobago,TT,TTO,780,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2016,91,Total,Units,%,Estimated value,Free,,12 to 23 months old
Trinidad and Tobago,TT,TTO,780,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2017,93,Total,Units,%,Estimated value,Free,,12 to 23 months old
Trinidad and Tobago,TT,TTO,780,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2018,99,Total,Units,%,Estimated value,Free,,12 to 23 months old
Trinidad and Tobago,TT,TTO,780,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2019,93,Total,Units,%,Estimated value,Free,,12 to 23 months old
Trinidad and Tobago,TT,TTO,780,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2020,95,Total,Units,%,Estimated value,Free,,12 to 23 months old
Trinidad and Tobago,TT,TTO,780,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2021,95,Total,Units,%,Estimated value,Free,,12 to 23 months old
Trinidad and Tobago,TT,TTO,780,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2022,93,Total,Units,%,Estimated value,Free,,12 to 23 months old
Tunisia,TN,TUN,788,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2020,87,Total,Units,%,Estimated value,Free,,12 to 23 months old
Tunisia,TN,TUN,788,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2021,96,Total,Units,%,Estimated value,Free,,12 to 23 months old
Tunisia,TN,TUN,788,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2022,98,Total,Units,%,Estimated value,Free,,12 to 23 months old
Turkmenistan,TM,TKM,795,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2020,23,Total,Units,%,Estimated value,Free,,12 to 23 months old
Turkmenistan,TM,TKM,795,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2021,97,Total,Units,%,Estimated value,Free,,12 to 23 months old
Turkmenistan,TM,TKM,795,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2022,98,Total,Units,%,Estimated value,Free,,12 to 23 months old
Tuvalu,TV,TUV,798,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2022,83,Total,Units,%,Estimated value,Free,,12 to 23 months old
Turkey,TR,TUR,792,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2009,97,Total,Units,%,Estimated value,Free,,12 to 23 months old
Turkey,TR,TUR,792,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2010,93,Total,Units,%,Estimated value,Free,,12 to 23 months old
Turkey,TR,TUR,792,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2011,96,Total,Units,%,Estimated value,Free,,12 to 23 months old
Turkey,TR,TUR,792,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2012,97,Total,Units,%,Estimated value,Free,,12 to 23 months old
Turkey,TR,TUR,792,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2013,97,Total,Units,%,Estimated value,Free,,12 to 23 months old
Turkey,TR,TUR,792,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2014,96,Total,Units,%,Estimated value,Free,,12 to 23 months old
Turkey,TR,TUR,792,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2015,97,Total,Units,%,Estimated value,Free,,12 to 23 months old
Turkey,TR,TUR,792,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2016,98,Total,Units,%,Estimated value,Free,,12 to 23 months old
Turkey,TR,TUR,792,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2017,96,Total,Units,%,Estimated value,Free,,12 to 23 months old
Turkey,TR,TUR,792,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2018,97,Total,Units,%,Estimated value,Free,,12 to 23 months old
Turkey,TR,TUR,792,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2019,97,Total,Units,%,Estimated value,Free,,12 to 23 months old
Turkey,TR,TUR,792,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2020,95,Total,Units,%,Estimated value,Free,,12 to 23 months old
Turkey,TR,TUR,792,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2021,96,Total,Units,%,Estimated value,Free,,12 to 23 months old
Turkey,TR,TUR,792,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2022,95,Total,Units,%,Estimated value,Free,,12 to 23 months old
Uganda,UG,UGA,800,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2014,60,Total,Units,%,Estimated value,Free,,12 to 23 months old
Uganda,UG,UGA,800,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2015,64,Total,Units,%,Estimated value,Free,,12 to 23 months old
Uganda,UG,UGA,800,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2016,77,Total,Units,%,Estimated value,Free,,12 to 23 months old
Uganda,UG,UGA,800,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2017,90,Total,Units,%,Estimated value,Free,,12 to 23 months old
Uganda,UG,UGA,800,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2018,92,Total,Units,%,Estimated value,Free,,12 to 23 months old
Uganda,UG,UGA,800,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2019,92,Total,Units,%,Estimated value,Free,,12 to 23 months old
Uganda,UG,UGA,800,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2020,89,Total,Units,%,Estimated value,Free,,12 to 23 months old
Uganda,UG,UGA,800,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2021,91,Total,Units,%,Estimated value,Free,,12 to 23 months old
Uganda,UG,UGA,800,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2022,90,Total,Units,%,Estimated value,Free,,12 to 23 months old
United Arab Emirates,AE,ARE,784,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2010,94,Total,Units,%,Estimated value,Free,,12 to 23 months old
United Arab Emirates,AE,ARE,784,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2011,95,Total,Units,%,Estimated value,Free,,12 to 23 months old
United Arab Emirates,AE,ARE,784,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2012,96,Total,Units,%,Estimated value,Free,,12 to 23 months old
United Arab Emirates,AE,ARE,784,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2013,98,Total,Units,%,Estimated value,Free,,12 to 23 months old
United Arab Emirates,AE,ARE,784,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2014,99,Total,Units,%,Estimated value,Free,,12 to 23 months old
United Arab Emirates,AE,ARE,784,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2015,99,Total,Units,%,Estimated value,Free,,12 to 23 months old
United Arab Emirates,AE,ARE,784,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2016,99,Total,Units,%,Estimated value,Free,,12 to 23 months old
United Arab Emirates,AE,ARE,784,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2017,96,Total,Units,%,Estimated value,Free,,12 to 23 months old
United Arab Emirates,AE,ARE,784,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2018,99,Total,Units,%,Estimated value,Free,,12 to 23 months old
United Arab Emirates,AE,ARE,784,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2019,99,Total,Units,%,Estimated value,Free,,12 to 23 months old
United Arab Emirates,AE,ARE,784,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2020,84,Total,Units,%,Estimated value,Free,,12 to 23 months old
United Arab Emirates,AE,ARE,784,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2021,95,Total,Units,%,Estimated value,Free,,12 to 23 months old
United Arab Emirates,AE,ARE,784,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2022,95,Total,Units,%,Estimated value,Free,,12 to 23 months old
United Kingdom,GB,GBR,826,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2010,89,Total,Units,%,Estimated value,Free,,12 to 23 months old
United Kingdom,GB,GBR,826,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2011,90,Total,Units,%,Estimated value,Free,,12 to 23 months old
United Kingdom,GB,GBR,826,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2012,92,Total,Units,%,Estimated value,Free,,12 to 23 months old
United Kingdom,GB,GBR,826,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2013,93,Total,Units,%,Estimated value,Free,,12 to 23 months old
United Kingdom,GB,GBR,826,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2014,93,Total,Units,%,Estimated value,Free,,12 to 23 months old
United Kingdom,GB,GBR,826,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2015,93,Total,Units,%,Estimated value,Free,,12 to 23 months old
United Kingdom,GB,GBR,826,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2016,92,Total,Units,%,Estimated value,Free,,12 to 23 months old
United Kingdom,GB,GBR,826,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2017,92,Total,Units,%,Estimated value,Free,,12 to 23 months old
United Kingdom,GB,GBR,826,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2018,92,Total,Units,%,Estimated value,Free,,12 to 23 months old
United Kingdom,GB,GBR,826,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2019,91,Total,Units,%,Estimated value,Free,,12 to 23 months old
United Kingdom,GB,GBR,826,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2020,91,Total,Units,%,Estimated value,Free,,12 to 23 months old
United Kingdom,GB,GBR,826,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2021,91,Total,Units,%,Estimated value,Free,,12 to 23 months old
United Kingdom,GB,GBR,826,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2022,90,Total,Units,%,Estimated value,Free,,12 to 23 months old
"Tanzania, United Republic of",TZ,TZA,834,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2013,80,Total,Units,%,Estimated value,Free,,12 to 23 months old
"Tanzania, United Republic of",TZ,TZA,834,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2014,93,Total,Units,%,Estimated value,Free,,12 to 23 months old
"Tanzania, United Republic of",TZ,TZA,834,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2015,92,Total,Units,%,Estimated value,Free,,12 to 23 months old
"Tanzania, United Republic of",TZ,TZA,834,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2016,89,Total,Units,%,Estimated value,Free,,12 to 23 months old
"Tanzania, United Republic of",TZ,TZA,834,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2017,86,Total,Units,%,Estimated value,Free,,12 to 23 months old
"Tanzania, United Republic of",TZ,TZA,834,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2018,84,Total,Units,%,Estimated value,Free,,12 to 23 months old
"Tanzania, United Republic of",TZ,TZA,834,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2019,83,Total,Units,%,Estimated value,Free,,12 to 23 months old
"Tanzania, United Republic of",TZ,TZA,834,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2020,80,Total,Units,%,Estimated value,Free,,12 to 23 months old
"Tanzania, United Republic of",TZ,TZA,834,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2021,80,Total,Units,%,Estimated value,Free,,12 to 23 months old
"Tanzania, United Republic of",TZ,TZA,834,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2022,83,Total,Units,%,Estimated value,Free,,12 to 23 months old
United States,US,USA,840,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2008,93,Total,Units,%,Estimated value,Free,,12 to 23 months old
United States,US,USA,840,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2009,93,Total,Units,%,Estimated value,Free,,12 to 23 months old
United States,US,USA,840,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2010,93,Total,Units,%,Estimated value,Free,,12 to 23 months old
United States,US,USA,840,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2011,94,Total,Units,%,Estimated value,Free,,12 to 23 months old
United States,US,USA,840,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2012,92,Total,Units,%,Estimated value,Free,,12 to 23 months old
United States,US,USA,840,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2013,92,Total,Units,%,Estimated value,Free,,12 to 23 months old
United States,US,USA,840,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2014,93,Total,Units,%,Estimated value,Free,,12 to 23 months old
United States,US,USA,840,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2015,93,Total,Units,%,Estimated value,Free,,12 to 23 months old
United States,US,USA,840,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2016,93,Total,Units,%,Estimated value,Free,,12 to 23 months old
United States,US,USA,840,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2017,92,Total,Units,%,Estimated value,Free,,12 to 23 months old
United States,US,USA,840,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2018,92,Total,Units,%,Estimated value,Free,,12 to 23 months old
United States,US,USA,840,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2019,92,Total,Units,%,Estimated value,Free,,12 to 23 months old
United States,US,USA,840,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2020,82,Total,Units,%,Estimated value,Free,,12 to 23 months old
United States,US,USA,840,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2021,82,Total,Units,%,Estimated value,Free,,12 to 23 months old
United States,US,USA,840,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2022,84,Total,Units,%,Estimated value,Free,,12 to 23 months old
Uruguay,UY,URY,858,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2010,91,Total,Units,%,Estimated value,Free,,12 to 23 months old
Uruguay,UY,URY,858,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2011,92,Total,Units,%,Estimated value,Free,,12 to 23 months old
Uruguay,UY,URY,858,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2012,93,Total,Units,%,Estimated value,Free,,12 to 23 months old
Uruguay,UY,URY,858,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2013,93,Total,Units,%,Estimated value,Free,,12 to 23 months old
Uruguay,UY,URY,858,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2014,95,Total,Units,%,Estimated value,Free,,12 to 23 months old
Uruguay,UY,URY,858,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2015,94,Total,Units,%,Estimated value,Free,,12 to 23 months old
Uruguay,UY,URY,858,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2016,94,Total,Units,%,Estimated value,Free,,12 to 23 months old
Uruguay,UY,URY,858,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2017,94,Total,Units,%,Estimated value,Free,,12 to 23 months old
Uruguay,UY,URY,858,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2018,93,Total,Units,%,Estimated value,Free,,12 to 23 months old
Uruguay,UY,URY,858,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2019,95,Total,Units,%,Estimated value,Free,,12 to 23 months old
Uruguay,UY,URY,858,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2020,94,Total,Units,%,Estimated value,Free,,12 to 23 months old
Uruguay,UY,URY,858,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2021,94,Total,Units,%,Estimated value,Free,,12 to 23 months old
Uruguay,UY,URY,858,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2022,94,Total,Units,%,Estimated value,Free,,12 to 23 months old
Uzbekistan,UZ,UZB,860,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2017,99,Total,Units,%,Estimated value,Free,,12 to 23 months old
Uzbekistan,UZ,UZB,860,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2018,96,Total,Units,%,Estimated value,Free,,12 to 23 months old
Uzbekistan,UZ,UZB,860,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2019,99,Total,Units,%,Estimated value,Free,,12 to 23 months old
Uzbekistan,UZ,UZB,860,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2020,93,Total,Units,%,Estimated value,Free,,12 to 23 months old
Uzbekistan,UZ,UZB,860,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2021,98,Total,Units,%,Estimated value,Free,,12 to 23 months old
Uzbekistan,UZ,UZB,860,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2022,99,Total,Units,%,Estimated value,Free,,12 to 23 months old
Vanuatu,VU,VUT,548,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2021,2,Total,Units,%,Estimated value,Free,,12 to 23 months old
Vanuatu,VU,VUT,548,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2022,42,Total,Units,%,Estimated value,Free,,12 to 23 months old
"Venezuela, Bolivarian Republic of",VE,VEN,862,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2015,24,Total,Units,%,Estimated value,Free,,12 to 23 months old
Venezuela,VE,VEN,862,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2015,24,Total,Units,%,Estimated value,Free,,12 to 23 months old
"Venezuela, Bolivarian Republic of",VE,VEN,862,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2016,7,Total,Units,%,Estimated value,Free,,12 to 23 months old
Venezuela,VE,VEN,862,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2016,7,Total,Units,%,Estimated value,Free,,12 to 23 months old
"Venezuela, Bolivarian Republic of",VE,VEN,862,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2017,0,Total,Units,%,Estimated value,Free,,12 to 23 months old
Venezuela,VE,VEN,862,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2017,0,Total,Units,%,Estimated value,Free,,12 to 23 months old
"Venezuela, Bolivarian Republic of",VE,VEN,862,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2018,0,Total,Units,%,Estimated value,Free,,12 to 23 months old
Venezuela,VE,VEN,862,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2018,0,Total,Units,%,Estimated value,Free,,12 to 23 months old
"Venezuela, Bolivarian Republic of",VE,VEN,862,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2019,0,Total,Units,%,Estimated value,Free,,12 to 23 months old
Venezuela,VE,VEN,862,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2019,0,Total,Units,%,Estimated value,Free,,12 to 23 months old
"Venezuela, Bolivarian Republic of",VE,VEN,862,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2020,0,Total,Units,%,Estimated value,Free,,12 to 23 months old
Venezuela,VE,VEN,862,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2020,0,Total,Units,%,Estimated value,Free,,12 to 23 months old
"Venezuela, Bolivarian Republic of",VE,VEN,862,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2021,0,Total,Units,%,Estimated value,Free,,12 to 23 months old
Venezuela,VE,VEN,862,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2021,0,Total,Units,%,Estimated value,Free,,12 to 23 months old
"Venezuela, Bolivarian Republic of",VE,VEN,862,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2022,0,Total,Units,%,Estimated value,Free,,12 to 23 months old
Venezuela,VE,VEN,862,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2022,0,Total,Units,%,Estimated value,Free,,12 to 23 months old
Yemen,YE,YEM,887,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2011,41,Total,Units,%,Estimated value,Free,,12 to 23 months old
Yemen,YE,YEM,887,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2012,67,Total,Units,%,Estimated value,Free,,12 to 23 months old
Yemen,YE,YEM,887,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2013,73,Total,Units,%,Estimated value,Free,,12 to 23 months old
Yemen,YE,YEM,887,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2014,73,Total,Units,%,Estimated value,Free,,12 to 23 months old
Yemen,YE,YEM,887,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2015,69,Total,Units,%,Estimated value,Free,,12 to 23 months old
Yemen,YE,YEM,887,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2016,71,Total,Units,%,Estimated value,Free,,12 to 23 months old
Yemen,YE,YEM,887,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2017,68,Total,Units,%,Estimated value,Free,,12 to 23 months old
Yemen,YE,YEM,887,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2018,64,Total,Units,%,Estimated value,Free,,12 to 23 months old
Yemen,YE,YEM,887,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2019,72,Total,Units,%,Estimated value,Free,,12 to 23 months old
Yemen,YE,YEM,887,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2020,72,Total,Units,%,Estimated value,Free,,12 to 23 months old
Yemen,YE,YEM,887,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2021,72,Total,Units,%,Estimated value,Free,,12 to 23 months old
Yemen,YE,YEM,887,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2022,74,Total,Units,%,Estimated value,Free,,12 to 23 months old
Zambia,ZM,ZMB,894,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2014,77,Total,Units,%,Estimated value,Free,,12 to 23 months old
Zambia,ZM,ZMB,894,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2015,81,Total,Units,%,Estimated value,Free,,12 to 23 months old
Zambia,ZM,ZMB,894,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2016,94,Total,Units,%,Estimated value,Free,,12 to 23 months old
Zambia,ZM,ZMB,894,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2017,94,Total,Units,%,Estimated value,Free,,12 to 23 months old
Zambia,ZM,ZMB,894,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2018,90,Total,Units,%,Estimated value,Free,,12 to 23 months old
Zambia,ZM,ZMB,894,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2019,89,Total,Units,%,Estimated value,Free,,12 to 23 months old
Zambia,ZM,ZMB,894,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2020,85,Total,Units,%,Estimated value,Free,,12 to 23 months old
Zambia,ZM,ZMB,894,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2021,89,Total,Units,%,Estimated value,Free,,12 to 23 months old
Zambia,ZM,ZMB,894,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2022,78,Total,Units,%,Estimated value,Free,,12 to 23 months old
Zimbabwe,ZW,ZWE,716,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2012,21,Total,Units,%,Estimated value,Free,,12 to 23 months old
Zimbabwe,ZW,ZWE,716,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2013,95,Total,Units,%,Estimated value,Free,,12 to 23 months old
Zimbabwe,ZW,ZWE,716,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2014,91,Total,Units,%,Estimated value,Free,,12 to 23 months old
Zimbabwe,ZW,ZWE,716,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2015,87,Total,Units,%,Estimated value,Free,,12 to 23 months old
Zimbabwe,ZW,ZWE,716,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2016,90,Total,Units,%,Estimated value,Free,,12 to 23 months old
Zimbabwe,ZW,ZWE,716,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2017,89,Total,Units,%,Estimated value,Free,,12 to 23 months old
Zimbabwe,ZW,ZWE,716,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2018,89,Total,Units,%,Estimated value,Free,,12 to 23 months old
Zimbabwe,ZW,ZWE,716,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2019,90,Total,Units,%,Estimated value,Free,,12 to 23 months old
Zimbabwe,ZW,ZWE,716,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2020,86,Total,Units,%,Estimated value,Free,,12 to 23 months old
Zimbabwe,ZW,ZWE,716,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2021,88,Total,Units,%,Estimated value,Free,,12 to 23 months old
Zimbabwe,ZW,ZWE,716,Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),2022,90,Total,Units,%,Estimated value,Free,,12 to 23 months old
